http://www.biotechdaily.com.au/pages/back-copies.php

Back copies

View recent copies of Biotech Daily with important stories on research and development (R&D), mergers and acquisitions (M&A), finance, government grants and regulation, share price movements, industry news and personnel appointments in Australian Stock Exchange listed biotechnology companies.

All articles include the company name and many have senior personnel in the headline. The easiest way to search is by using the 'find' function under 'edit' on the main toolbar.

This website is best viewed using the Firefox browser

 

Mar 1, 2010 February BDI-40 Falls, Leads S&P ASX200; Heartware  Up 34%, Cathrx Down 47%

 

Mar 1, 2010	Feb 26, 2010	Feb 25, 2010
Feb 24, 2010	Feb 23, 2010	Feb 22, 2010
Feb 19, 2010	Feb 18, 2010	Feb 17, 2010
Feb 16, 2010 Bioguide Brief: Quattuordecim Dies Horribilis - Avexa, Chemgenex, CBio; Brain Resource Blames Foreign Exchange For Profit Fall; Genetic Technologies Sues Monsanto, 8 Others On Patents; Federal Court: Select's Dr Martin Soust Manipulated Market; Nusep H1 Revenue Up, Loss Down, Maiden 'Operational Profit'; Five Organizations Collaborate On Research 'Bio-Bank'	Feb 15, 2010 Avexa's ATC For HIV Resistance-Free, Efficacious At 144 Weeks; High Court Ends UWA v Dr Bruce Gray (Sirtex) Case; Cellestis H1 Revenue, Profit, Dividend Up; Psivida H1 Revenue Up, Cash Burn Down; CBio Opens Down 50%; Tissue Therapies Chairman Gives 2m Shares To Key Staff; Bio-Melbourne Breakfasts In Prof Michael Cowley, Obesity, Diabetes	Feb 12, 2010 Swedish 10-Year Study Supports Impedimed Care Model; Nanosonics H1 Revenue Up, Loss Down, Appoints Richard England; New Zealand Grants $3m For Living Cell Trial; Bio-Asia Ceased In Neuren In 2008
Feb 11, 2010 Sirtex, Bayer Schering Collaborate On Liver Cancer; UK Ethics Approval For Healthlinx Ovarian Cancer Study; Correction: Clinuvel; Neuren Partners With Cato, Appoints US Chief Medical Officer; CBio Admitted To ASX; Biosignal Back In Lists, For Now; Polartechnics Goes to The Wall, Shareholders Lose The Lot; Karmelsonix Appointments	Feb 10, 2010 QRX Begins 2nd Phase III Pain Trial; Commercialisation Australia Board Biotech-Experienced; Biosignal Votes On IP Sale, Name, Direction Change; Clinuvel Shelves Two of Five Afamelanotide Indications; Healthlinx names AGR2 As Ovarian Cancer Test Protein; Narhex - Administrators Appointed	Feb 9, 2010 Commercialisation Australia: Lack Of Detail, But Apply Now; Chemgenex Dismisses FDA Data Interpretation; Bioguide Brief: Chemgenex, The FDA & Tough Questions; Cochlear Record H1 Profit Up 8% On Revenue Down 2%; Pharmaxis PXS25 Passes Phase I, Completes Topigen Purchase; Computershare UK Resolves Stem Cell Payments; Living Cell Takes 10% Of US Wound Healing Company; Uscom Revenue Up, Loss Down; Ellex Expects Increased Earnings
Feb 8, 2010 CBio IPO Raises $7m, Opens East Euro Arthritis Sites; OBJ Says Unnamed Company Continues Collaboration; Asia Union Ceases Substantial In Anteo; Andrew Goodall Takes 15% Of Nusep	Feb 5, 2010 Bioguide Brief: Tough Road Ahead For Avexa's ATC; Resmed Record Q2, H1 Revenue, Profit; Biota's Record $33m Relenza Royalty; Taiwan Approves Cellestis Quantiferon-TB Gold in-Tube; Benitec Benefits 130% From Pfizer Option On Tacere; Circadian Companies Reduce 5% In Antisense; Medical Developments Loses CEO Chris Rossidis; Solagran Tells ASX: Expect $17m Sales By Year End	Feb 4, 2010 Avexa's Phase III HIV Trial: Non-Significant ATC Benefit; WEHI Leads Research On Malaria Parasite Protein Target; GTG'S Dr Mervyn Jacobson, Tamara Newing Committed To Trial; Genesis Plan To Raise $485k; Kinetic Ceases Substantial In Nanosonics
Feb 3, 2010 Antisense Up 300% On Journal Publication, Patent; Heartware Completes $71m Raising; Phosphagenics Elixia Cosmetics 'Scientifically Proven'; Solagran Requests 'Russian Drug Licence' Trading Halt	Feb 2, 2010 Bionomics Anti-Anxiety Drug Enhances Nerve Cell Growth; Euro Patent For LBT; US Study Backs Atcor Measure For LV Hypertrophy	Feb 1, 2010 January BDI-40: ASX Fall Stretches Biotech Lead - Viralytics Up 100%, Patrys 61%, Mesoblast 50%; Phosphagenics Transdermal Oxycodone Patch 'Success'; Australian Ethical Ceases Substantial In Genera; Genetic Technologies Committal Hearing Begins; Biota: Daiichi Sankyo Applies For Japan LANI Registration; Starpharma, Eli Lilly Human Drug Development Deal; Commercialisation Australia For Bio-Breakfast; Cytopia All But Gone To YM Biosciences; Hunter Hall Takes 35% Of Fluorotechnics
Jan 29, 2010 Computershare Replaces Stem Cell Cheques; Compumedics Sells $929k Grael To Heidelberg; Xceed Raises $1m; USPTO Allows Benitec Graham '099-Related Patent; Biotech Daily Appendix 4C, H1, Final Report Policy; Giaconda Has Little Cash, $250k Loan, Raising Planned; Norwood Abbey Has One Quarter Cash, Coal Deal; Solagran Has One Quarter Cash; Pharmaust Clean Room 4 Sale	Jan 28, 2010 Correction: ASIC, DPP, GTG; Universal Bio's 1st (J&J Lifescan) Product On Dutch Market; Patrys, CSL Collaborate On Antibodies; Virax Raises $1.3m; US Army's $502k For Avita's Recell Wound Treatment; Atcor Revenue Underpins Cash; Heartware $US55m Raising Details; JM Buys Genera, Aust Ethical Sells; Narhex Chairman David Mandel Resigns; Bioprospect Raises $740k	Jan 27, 2010 Bionomics Begins Phase II BNC105 Renal Cell Cancer Trial; Living Cell Warning On Fake Shares; Acrux Submits Axiron Testosterone Application; Heartware Nasdaq IPO To Raise $US50m; Cogstate Record Revenue Up 31%; Anteo Has 2 Quarters Cash, Options Raising Funds; Ausbiotech Not Happy With Notitia Conference
Jan 25, 2010 Ex-Genetic COO Geoff Newing Pleads Guilty On Shares; Administrators Call OMI Meeting; Two Medical Directors Strengthen Sirtex's US Operations; Dr Peter Farrell, Mel Bridges At innovation Lunch	Jan 22, 2010 FDA Approves Compumedics ' HD-PSG Grael Sleep Diagnostic; Asset Realisation (Stem Cell Sciences) Cheque Pain; TGA Approves Genera Paptype HPV Test; Ellex Launches 'Gentler' Eye Laser In Tokyo; Healthlinx Expands Liverpool Research; Nanosonics Plan Raises $3.6m; Stirling Raises $2m; Prima Appoints Zurich's Matthew Lehman COO	Jan 21, 2010 Avita Passes ISO Audit For CE Mark; Fluorotechnics Raises $1.8m; Biomd Has Less Than Two Quarters Cash, Proposed Raising
Jan 20, 2010 Living Cell: Euro Patent, Journal Back NTCell Pig Brain Cells; Eurogentec To Make Tissue Therapies' Vitrogro; Optiscan Chairman Angus Holt Replaces CEO Vicki Tutungi; Cathrx Sales Up, Downgrades Forecast; Genera Requests 'Regulatory' Trading Halt; Unaval Takes 6% Of Virax; Bone Appoints Dr Lee Simon; Bye-Bye Rockeby	Jan 19, 2010 Viralytics Up 200% On Phase I Cavatak Melanoma Success; WEHI Melbourne Uni Identify Proteins For Malaria Vaccine; Eastland Subsidiary Sale Improves Cash By $1.8m	Jan 18, 2010 Phylogica, Isogenica Collaborate On Inflammatory Disease; Cytopia Has Left The Building; $2.7m Property Sale Leaves Pharmaust Debt-Free

 

Jan 17, 2010 Special Summer Catch-Up Edition: Phylogica; OMI; Commercialisation Australia; R&D Tax Credit; Leo-Peplin; Acuvax-Hawaii; Xceed, Calzada, Polynovo; Psivida; Merck-Biodiem; Alchemia; Avexa; FDA-Pharmaxis; Benitec-CSIRO; Uscom; Agenix; Tissue Therapies; Pharmaxis-Topigen; Cytopia-YM Bio; Ante; Probiotec, Biotron	Jan 4, 2010 2009: Biotechs Climb 5-Times Faster Than ASX200; BDI-20 Up 155%, ASX200 Up 31%, Prima Up 4700%, Biota Up 643%	Dec 18, 2009 Mesoblast Cells Show Diabetes Potential In Mice; Non-Significant Results Take Clinuvel To 2nd PLE Phase III Trial; Viralytics Increases Head, Neck Cancer Dose; Biotech Win In Federal $64m For Fund Managers; Bionomics Appoints Trevor Thiele CFO Co Sec; WEHI Pores Finding Shows Cancer Disease Targets; Ausbiotech Takes 10 To San Francisco Show
Dec 17, 2009 Editorial: The Year In Review; FDA Sets Feb 2010 Date With Chemgenex; Pharmaxis Applies To TGA For Bronchitol For Cystic Fibrosis; Leon Carr Appeals NSW Court Order; Fluorotechnics Rights Issue To Raise $1.8m; Biotron: BIT225 Cuts HIV Load 99% In Vitro; Ellex Downgrades H1 Revenue Forecast; FDA Grants Clinuvel Additional Orphan Status; Genetic Technologies Evaluates Breast Cancer Test; Correction: Nanosonics; Phosphagenics Insulin Patch 'On-Track For 2010 Trials'	Dec 16, 2009 NSW Judge: Fermiscan's Leon Carr 'Dishonest', Referred To ASIC; Correction: Fermiscan; Immuron Begins Israeli Phase II Insulin Trial; Biota Pleads Schultz To ASX 27% Price Fall Query, ATO Ruling; Wilson HTM Takes 5% Of Nanosonics; Biotech CRCs Win Lion's Share Of $130m, 2010 Round Opens; Virax $1.3m Rights Issue 50% Underwritten; Chinese Parties Fail To Pay, Complete Agenix Deed; Uscom Appoints Prof David Bennett Advisor	Dec 15, 2009 Phosphagenics Phospha-E Fails Nestle Fat Trial; Merck Serono Spends $1.6bn On R&D; Impedimed: Asia Distributor, US Legal Action, Escrow Shares; Halcygen Asks Hospira To Transfer Assets To Mayne; Federal Government $50m For Bionic Eye Research; Biomd Tests Adapt Tissue Biocompatibility; Biopharmica's Cortical Dynamics Finishes Monitor Research; Blackrock Takes 5% Of Cochlear; Fermiscan Assets For Sale, Leon Carr In NSW Court
Dec 14, 2009 Chemgenex In $137m Hospira Non-US Deal; Bioguide Brief: A $137m Positive Signal; Hawaii CEO Files For Bankruptcy Before Acuvax Board Coup; OMI v RTI Retractable Trial Begins In East Texas; Biosignal's $20m To Go To The Movies;  Safety Medical Raises $143k Of $1m; Australian Ethical Takes 8.4% Of Tissue Therapies; Avita Pleads Schultz To ASX 18% Query	Dec 11, 2009 Australian Stem Cell Centre Therapy Handbook; $40k Victorian Young Researcher Awards Open; Biotron's Underwritten $2m Double Option Offer; Cyclopharm US Trial Delay, Wins $2m Clinquest Claim; ASIC Approves Cytopia AGM Delay; Unilife Pleads Schultz To 18.5% Share Price Fall	Dec 10, 2009 CSL's R&D Pipeline Focus On Cardiac, Dental Disease; Living Cell Welcomes NHMRC Advice To Lift Xenotransplant Ban; Biota CEO Peter Cook Defends Tamiflu From BMJ Article; Eastland Governance EGM; Universal Biosensors Banks $17.5m, Ships 1st Glucose Strips; J&J Tibotec Extends Avexa Option 4 Months; Virax Applies For US Patent; Karmelsonix Australian Distributor; Solagran Pleads Schultz To ASX 26% Price Fall Query
Dec 9, 2009 Chemgenex's Omapro Effective In 2nd Phase II/III CML Trial; ASX Approves CBio Listing, IPO Extended; Bionomics' 2nd Phase II BNC105 Trial For Mesothelioma; Clinuvel: Afamelanotide 'Helps GI Cancer Treatment'; Court Approves Cytopia's Toronto Takeover Meeting; Pallane Issues $400k Note, Pursues Diabetes Drug; Karmelsonix Raises $4.5m	Dec 8, 2009 Eastland Reviews Potential ASIC, ASX Breaches; Cathrx Changes Germanic Distributor; FDA Approves Avita's US Recell Trial; Phylogica Raises $2m; Sophie Mirabella Appointed Shadow Innovation Minister; CSL Leadership Changes, CFO Tony Cipa To Retire; Asia Union Takes 8.6% Of Anteo; Xceed Rights issue Raises $1m, George Cameron-Dow M-D	Dec 7, 2009 CSIRO, Circadian, Monash $15m Protein Facility; Chemgenex CML 81-Patient Omapro Data; Ondek Starts Helicobacter Vaccine Trial;  Nanosonics' $12m Placement, Share Plan; Oversubscribed Tissue Therapies Plan Raises $2.7m; OMI Founder Bruce Kiehne Retires; Court Approves Unilife US Move; Pacific Super Diluted To 8% Of Agenix
Dec 4, 2009 Victorian $1.5m For Breast Cancer Stem Cell Research; Living Cell's 1st NZ Diabetes Patient Reduces Insulin 30%; Biota Joins S&P ASX200; Aust Ethical Takes 7.7% Of Tissue Therapies; Orbis Takes 6.5% Of Avexa; National innovation Principles Adopted	Dec 3, 2009 Biotech Takes $30m In ARC Grants, $1.5m For Monash Uni; Biopharmica Raises 'About $12m'; US FDA Fast Tracks Virax Licencee; Correction: Advanced Surgical; Karmelsonix India Distributor	Dec 2, 2009 Pharmaxis: Phase III Bronchitol Benefit For Cystic Fibrosis; Phosphagenics' Phase Ib Oxycodone Trial; Healthlinx Ovarian Cancer Test In UK in 2010; Advanced Surgical Euro, TGA Approvals; Agenix Closer To China Resolution; GSK, Optiscan Appointments To IP Council
Dec 1, 2009 BDI-40 Up 155% In 12 Months, Up 6.8% In November - ASX200 Up 1.3%; Axing Comet: i) Senator Eric Abetz - 'Just bring Back Commercial Ready'; ii) Ausbiotech's Dr Anna Lavelle - 'An Effective Program Lost'; Progen Appoints Dr John Chiplin Interim CEO; Novogen Loses CEO Chris Naughton; Prima Share Plan Raises $11m; Freiburg Uni Spends $600k On Compumedics' New Kit; Patrys Releases 11.3m Escrow Shares; Genera Appoints Tony Panther CFO	Nov 30, 2009 Federal Government Axes $14m Comet Program; Who Owns Pallane Medical?; Avexa Placement Raises $8m, Share Plan To Raise $3m; QRX Begins Pivotal Phase III Moxduo Pain Trial; Goodbye Metabolic, Welcome Calzada; Federal Government Call For Submissions On Trials; Healthlinx Places $1m; Clinuvel Wins Euro SME Status; Acuvax, Mesoblast AGMs	Nov 27, 2009 Europe Accepts Chemgenex Omacetaxine Application; ASIC Restricts (Dia-B) Pallane's $30m Fortrend Facility; Au Revoir Peplin; Giaconda Dissent On All Resolutions; Cochlear Wins Federal Innovation Gong; Vaxine Wins Cool Award For Non-Virus 'Flu Vaccine; WEHI's Dr Guillaume Lessene Wins $5k Biota Prize; Bioprospect Appoints CEO Peter May COO
Nov 26, 2009 Prima Share Plan Raises $9.6m; Cellmid Raises $4m, CEO Maria Halasz Contract Renewed; Avexa Funding Trading Halt; 2 Progen Directors Go, Board Deal Done; Healthlinx AGM Split On White Knight Stephen Copoulos; 2nd Core Australian Patent For Tissue Therapies Vitrogro; Aust Ethical Down 1% In Genera; Stirling Hopes To Raise $1.5m; Solagran's Dr Soultanov Misses Russia's President Medvedev	Nov 25, 2009 Fortrend Investing In Struggling Biotechs; Alchemia Rights Issue To Raise $15.5m For Phase III Trial; Neuren Appoints QRX's Dr John Holaday Director; Genetic Technologies Losies Co-Founder Fred Bart, Gains Tom Bonvino; 2nd Core US Patent For Tissue Therapies; Orbis Takes 8% Of Starpharma; CVC Takes 19% Of Cyclopharm; Living Cell Appoints Peter Hosking	Nov 24, 2009 Cytopia Begins Dosing Phase I/II CYT387 Myelofibrosis Trial; Eastland Starts Rwanda Malaria Trial; Biopharmica's ASIC Xmas Eve EGM, Late AGM; Cellmid Funding Trading Halt; Heartware Applies For FDA Destination Therapy Trial; US Patent For Antisense ATL1103, Trial In 2010; Sydney Uni Study Backs Impedimed's Device For Lymphoedema; Tyrian To Launch 2nd Crop Test; Immuron's Arie Nudel Survives AGM; Viralytics AGM; Probiomics Signs Denmark's Hansen Global Distributor
Nov 23, 2009 Tissue Therapies' Fremantle Trial Reduces Venous Ulcers 75%; Fluorotechnics Appoints Protea For North American Sales; FDA Committee Backs Pharmaxis' Aridol Application; Mater Hospital Approves Healthlinx Ovplex Study; Nycomed Distributes Immuron's Travelan; 19% Oppose Psivida's Automatic Stock Increases; 24% Oppose Metabolic's David Kenley, Calzada Approved; Viralytics Appoints Prof Hardev Pandha; Acuvax Appoints Dr Alex Birrell; Prima Appoints Dr Neil Frazer CMO	Nov 20, 2009 Safety Medical Hungarian Deal Change; Share Plan Extended; Advanced Surgical Releases 16.8m Escrow Shares; 20% Oppose Eastland Stock Issue, 13% Oppose CEO; Dia-B Becomes Pallane On ASX; Labtech Changes Name To LBT Innovations	Nov 19, 2009 Progen Settlement Costs $1.8m, Board Seats, Justus Homburg; Bioguide Brief: Progen - More Truce Than Resolution; Vale Narhex's Dr Michael Cohen; Federal Government Gives Yuuwa Capital $20m To Invest $40m; Viralytics 'Knows Nussink, Nussink At All' About 75% Price Rise; Living Cell, Genera AGMs; Nanosonics Pleads Schultz, Good News To ASX Query; Texas Children's Hospital Buys Uscom Device; Virax Passes 2nd Data Safety Board Report; Immuron Appoints Grant Rawlin CEO, Dr Elane Zelcer Director
Nov 18, 2009 Tissue Therapies: 'Outstanding' Vitrogro Ulcer Results; Mesoblast '6-Month Improvement In Heart Muscle Function'; Starpharma Raises $16m For Vaginosis Trial; Neuren Raises $8m For Traumatic Brain Injury Trial; Fermiscan Administrators Appointed; Prima To Develop Oral Cervical Cancer Vaccine; Avexa Loses 6-Month Director Lawrence Gozlan; Avexa, Clinuvel AGMs; Goodbye Medical Therapies, G'Day Cellmid	Nov 17, 2009 Metabolic Takes 66% Of Polynovo; Xceed's Boron Cuts Costs, Sales Down, New Plant Near Ready; Fluorotechnics Tells ASX: 'Cash Flow Positive In Q1 2010'; Biotron Tells ASX Trials Increased Cash Burn; Bio-Melbourne Breakfasts On Functional Food	Nov 16, 2009 Living Cell Plan To Raise $2m; Fluorotechnics Gels '20% Better Than Competition'; Avexa Pleads Schultz To ASX 21% Price Query, Up 100% In 40 Days; Karmelsonix Distribution Deals; Solagran Chairman Misses AGM To Meet Russian President
Nov 13, 2009 WAIMR Wins $609k Grant For Biopharmica's HLS5; Ellex, CERA Win $540k Victorian Grant For Laser AMD Trial; QRX Rights Issue, Placement Raise $21.6m; Progen-Medigen Case Undecided	Nov 12, 2009 Biota Acquires $12m Oxford, Boston Anti-Bacterial Pipeline; 5% Oppose Biota Pay Report, Chairman Dr Jim Approved; TGA Unsatisfied With FDA Approval For Acrux's Ellavie; Leo's Peplin Takeover Complete; $1m Aust Stem Cell Center Grants; Medical Therapies, Yamasa Sign Japan Distribution; Mark Fordree Smoothes Fermiscan's Pillow; Impedimed Applies For US Insurance Code	Nov 11, 2009 Cash-Strapped Fermiscan Loses Prof Veronica James Appeal; QRX Placement, Plan Trading Halt; CBIO Ready For $30m IPO; Rwanda Approves Eastland Malaria Trial; Patrys Collaborators Win $300k ARC Grant; Biotron: PNAS Article Supports P7 Hep C Target; Biomd EGM To Issue 30m Shares; Anteo Raises $1m; Verva Appoints Dr Michael Cowley Director
Nov 10, 2009 GSK Details Oncology Pipeline, Lung Cancer Vaccine; Universal Biosensors Milestone Earns $17m; FDA Accepts Chemgenex Omacetaxine NDA, Review In 6 Months; Unilife Plan Raises $21.5m; Cytopia's CYT997 'Profound' Vascular Disruption In Mice; Compumedics Germany Wins $200k Innovation Grant; Clinuvel EPP Phase III Trial December Close; Progen-Medigen Legal Fight; Bioprospect Appoints Solagran's Charles Pellegrino M-D	Nov 9, 2009 Acuvax Calls EGM To Roll 2 Hawaii Directors; JM Financial Takes 7% Of Halcygen; Biomd Begins Pelvic Floor Reconstruction Trial; Cyclopharm Installs Macquarie Uni Cyclotron; Resonance Wins Contracts, Increases Exposure; Melbourne Neuroscience Symposium	Nov 6, 2009 Biotech Daily 4th Birthday Editorial; Verva 1c Share Buy-Back; Resmed Q1 Revenue Up 13%, Profit Up 50%; Peplin Votes For Leo Merger, Depart ASX; Mesoblast Claims Bone-Marrow Success; Pharmaust Confirms $2.7m Property Sale; Morgan Stanley Takes 5% Of Prana; Acrux Appoints Credit Suisse
Nov 5, 2009 Biota, Daiichi Sankyo Start Phase III 'Flu Preventative Trial; Starpharma US Pesticide Deal; U of WA To Pay Sirtex $3.25m; Senator Kim Carr Opens $1.5m Cellular Imaging Facility; J&J's Tibotec Extends Avexa HIV Option; Heartware Q3 $7.5m Pump Revenue; Genera Placement Raises $2.3m; Optiscan Plan Raises $1.175m; Pokies Bruce Mathieson Takes 8% Of Halcygen	Nov 4, 2009 CEO Interview: Genetic Technologies' Dr Paul MacLeman - The Hottest Seat In Biotech; Phosphagenics' New York Anti-Ageing Cosmetic Launch; 3M To Evaluate OBJ Transdermal; Strong Share Price, $A Prompt Unilife Consolidation Change; Medical Developments 2nd Buy-Back; Solagran Schultz to ASX 30% Query	Nov 3, 2009 Prima Divests 'Non-Core' Panvax Product; Fluorotechnics Germany Wins $230k Innovation Grant; Helicon Halves Share Plan To $500k; Start-Up Takes 28% Of Bionomics
Nov 2, 2009 BDI-20 Up 134% For Year, Up 9.5% In October - ASX200 Down 2.1%; Hadassah Uses Immuron Colostrum For Fatty Livers; St George Joins Viralytics Cancer Trial; Novogen Withdraws Options, Remuneration Rolled; Cytopia Leaves Labs For St Kilda Rd; Peplin Votes On Leo Merger; Progen AGM Depends On Legal Action; Innovation Loses Adviser Tim Murphy To GSK; Rockeby AGM Votes To Delist	Oct 30, 2009 Advanced Surgical Sells Knee To Stryker For $3m; Avita Maiden Cash Flow Positive Quarter; Agenix Dumps Director Jonathan Zhang; Grant Makes Neuren Cash-Flow Positive, Schultz To ASX; Cash-Strapped: Bone, Fluorotechnics, Fermiscan, Giaconda, IM Medical, Solagran, Stirling; Rockeby Liquidates Subsidiaries	Oct 29, 2009 Victoria $3m For ATEC Breast Reconstruction, $750k For Healthlinx; Pharmaxis Files EU Bronchitol CF Application; Biota Earns $24m Relenza Royalty; Medical Therapies Licences Midkine To Celera; Royal Adelaide Joins Viralytics Cancer Trial;  Circadian Fights ARK Over VEGF-D; Compumedics German Sales Increase; David Rosa Replaces Sunshine Heart CEO Don Rohrbaugh; Chemgenex Votes On 2.2m CEO Options; Starpharma Withdraws 1.9m CEO Shares, Cites Tax Liability; JM Takes 5% Of Genera
Oct 28, 2009 Heart Risk Identified With Atcor's Sphygmacor; Living Cell Calls For End To Xenotransplant Ban; W.H.O. Licences Biodiem LAIV; Stirling Plan Raises $1.6m; Safety Medical To Raise $1m; Halcygen AGM Backs Mayne Merger, Board Stock Opposed; Victoria Expedites Approvals; Evado Launches Trial Management Software; Ausbiotech, GSK, Biota, PM Gongs - Dr Greg Collier, Dr Michael Cowley	Oct 27, 2009 Ausbiotech Conference Opens With Emphasis On Government Investment; Bionomics Phase I Anxiety Drug BNC210 'Safe, Tolerated'; Biotron Has One Quarter Cash; Unilife Brand Name Change; 'Positive Results' From Living Cell Russian Trial; Federal Government Inquiry To 'Boost Clinical Research'; Dr Bruce Gray Divides Sirtex AGM Again	Oct 26, 2009 Bio-Sciences, Biotech Win $85m ARC Grants; Unilife Wins $5.6m Pennsylvania State Grants; Impedimed Releases 7.5m Escrow Shares; Fluorotechnics Releases 361k Shares; Acuvax Plan Raises $164k; Ausbiotech On-Track For Conference Start; Fermiscan Trading Halt
Oct 23, 2009 Pharmaxis Phase III Bronchitol Trial Starts; Lymphoedema Journal Review Backs Impedimed Test; Genetic Tech Distributes Rosetta Tests;  Ellex Launches Eye Cubed Diagnostic; Healthlinx Collaborators; Solagran Slashes Ropren Sales Price; Stirling Inhaler Deal	Oct 22, 2009 Psivida's Brachysil Halts Pancreatic Tumors In 6-Patient Trial; Anteo Raises $865k; Progen Legal Action To Prevent Board Spill; 20% Oppose Pharmaxis CEO Options; Metabolic Votes On Name Change To Calzada; Japanese Patent For Prima; Incitive To Raise $750k	Oct 21, 2009 Federal Government Unveils 'Commercialization Australia'; Editorial: 'Radical Media Release, Fabulous Logo'; Liberal Senator Eric Abetz: 'Bring Back Commercial Ready'; Ausbiotech, Bio-Melbourne - Mixed Responses; QRX China Snake Venom Deal Done; Cochlear AGM Dissent
Oct 20, 2009 Evado Supports Malaysian Bowel Cancer Screen; Capital Increases In CSL; Cathrx Pleads Schultz To ASX 117% Query; Living Cell Directors Win Options With Cash	Oct 19, 2009 Sirtex Maiden Dividend; Tissue Therapies Raises $5m, Plan For $1.5m; Cytopia Opens 4th Glioma Trial Centre; Immuron Pays Ex-CEO Dr Zeil Rosenberg $65k; Bioprospect Tells ASX 'Update Pushed Price 52%'	Oct 16, 2009 Bionomics Anxiety Drug BNC210 'Non-Addictive' In Rats; Prima 15c Share Plan To Raise $5m; Clinuvel AGM; Labtech Name Change AGM; Genesis EGM
Oct 15, 2009 Becton Dickson, Tyrian Part Company On TB Test; Psivida Completes 2-Year Phase III DME Follow-Up; Progen's PG545 'Limits Spread Of Cancer'; Pharmaxis PXS25 Begins Phase I Lung Fibrosis Trial; Compumedics Launches Sominilin SPAP For Sleep Apnoea; TGA Approves Genera's Manufacturing; Bone Files US IND For Osteoarthritic Pain; Medical Therapies Vote On Name, $3m Raising, 9m Options	Oct 14, 2009 Monash, Neural Diagnostics Automate Psych Diagnoses; CSL Investors Back AGM Resolutions, 5% Dissent; Nobilon Begins Biodiem Intranasal 'Flu Vaccine Trial; Avexa Pleads Schultz To ASX 19% Query, Up 73% In Week; Psivida Votes On 'Incentive' Shares; ASX: $1.02 Floor Under Mesoblast 'Unusual, Not Manipulative'; Karmelsonix Votes On 159m Shares; Greg West Returns As Fermiscan Co Sec	Oct 13, 2009 Circadian Produces Anti-Cancer Compound; Incitive Ditches V-Patch Acquisition; UK Approves Halcygen Anti-Fungal PK Study; Countdown To Ausbiotech's 2009 Conference
Oct 12, 2009 Antisense ATL1103 Ready For Acromegaly, Retinopathy Trials; Biota Takes Off: 33.5c To $3.15 In 9 Months; Patheon Makes QRX's Moxduo CR For Trials; Helicon Plan To Raise $1m; Tyrian Votes On 5.5m CEO Rights; Starpharma Votes On 1.9m CEO 'Appreciation Shares'; Medical Therapies Snares Arana's Robin Beaumont	Oct 9, 2009 CBio Raises $10m, Ready For ASX IPO, XToll Arthritis Trials; Fermiscan's Future Very Uncertain; Cathrx 3-Month Sales Best Yet, Below Target; Apollo Reinstated; BAM 'Short Sells' 2.4% Of Prana; Link Reduces 1% In Prima; Acuvax-Hawaii Expects $1m In 2009	Oct 8, 2009 Bionomics Share Plan Raises $2.2m; Viralytics Accelerates Head, Neck Cancer Recruitment; Prima Pleads Schultz To ASX 87% Query; Eastland Pleads Schultz To 27% Query; Rockeby Reinstated To Delist; OMI Files Accounts, Remains Suspended
Oct 7, 2009 Bioguide Brief: Despite Price, Cytopia-YM Deal Good For Both; Living Cell Implants 1st NZ Diabetes Pig Cell Patient; UWA Takes Sirtex's Dr Bruce Gray 'Duty To Invent' To High Court; Unilife Places $32m, Share Plan To Raise $10m More; Optiscan Plan To Raise $1.5m	Oct 6, 2009 Toronto's YM Biosciences Buys Cytopia For $14m; Biotron's High-Dose BIT225 Reduces Hep C Viral Loads; Prof Blackburn's Nobel Good For Sienna; Cogstate Seals $4m In 3 Months; Sciclone Halts Acuvax RP101 Pancreatic Ca Trial; Heartware Increases Trial Sites; Labtech's First Microstreak Royalty; Patrys Buys Gastric Cancer Antibody; Benitec Option On 5 T-Cell Programs; Medical Therapies, Kumamoto Uni Collaboration	Oct 5, 2009 Bioguide Brief: Crunch Time For Avexa's Apricitabine; Dia-B's New Board Will Pursue Winteray; Fortrend's $30m To Keep Dia-B Biotech; Healthlinx' $7m Springtree Note; Genetic Tech Appoints Dr Malcolm Brandon Director; Helicon Back As Biotech, Gold Miner
Oct 2, 2009 Avexa Closes Phase III HIV Trial For Early Registration; Phosphagenics Plan Raises $7m; Helicon Branches Into Gold, Copper Mining; Fermiscan $4.5m Loss, Mark Fordree New CEO, Executive Leon Carr Goes	Oct 1, 2009 September BDI-40 Up 15%, Up 64% In 12 Months - 20 x S&P ASX 200; Benitec, Cancer Institute Collaborate On Lung Cancer; Peplin To Vote On Leo Takeover; OMI, Rockeby Suspended On Accounts; OBJ Transdermal Claims	Sep 30, 2009 Optiscan Trials World's First Dual High Definition Microscope; Resonance Develops Faster Liver Test; Novogen's NV-128 Safe, High Anti-Cancer Activity In Mice; Psivida High Dose Steroid Efficacy; Labtech's New Lab Solution; Uscom Raises $1m
Sep 29, 2009 Acrux Phase III Testosterone 'Success', Deal In 12 Months; Safety Medical - The Directors' Cut; Optiscan Pleads Schultz To ASX 89% Price Jump Query; JP Morgan Below 5% Of QRX Pharma; All Change At Norwood Abbey For China Coal Co	Sep 28, 2009 Halcygen Votes On 100m Mayne Pharma Shares, Share Plan; Bio-Melbourne Master Class On Grant Writing; JP Morgan Reduces 2.6% In QRX Pharma	Sep 25, 2009 Halcygen ($30m) Buys Back The Mayne Pharma ($300m+); Bioguide Brief: Why Is Halcygen Buying Mayne Pharma?; Agenix Files 2007-'08 Accounts; Dissent On Director Shares At Biodiem AGM; Uscom UK Launch October 1; Prima Pleads Schultz To ASX 27% Price Jump Query; Fermiscan Director Leon Carr Goes
Sep 24, 2009 Acrux Estradiol Euro-Deal Could Earn $25m; Psivida Starts Secondary Macular Oedema Iluvien Trial; QRX Snake Venom Alliance With China's Nuokang; Sunshine Heart Rights Issue Raises $8m; Compumedics' German Sales Up; Bioprospect Appoints Leo 'The Gun' Khouri Director; FDA Clears Karmelsonix Wheezometer	Sep 23, 2009 Probiotec To Raise $12m, Directors, Management Sell-Down; Aviva Takes 6% Of Mesoblast; Asia Union Takes 9% Of Cogstate; Living Cell Appoints Bob Finder, David McAuliffe Directors; Fermiscan Loses Gary Garton	Sep 22, 2009 Infection Risks Increase Nanosonics Demand; Nanosonics Pleads Old News To ASX 22% Price Query; Mesoblast Enrolls 2nd Cardiac Stem Cell Arm; $14.5m NSW Heart Facility; Viralytics Completes 2nd Phase I Melanoma Trial; Neuren Schultz To ASX 46% Price Query
Sep 21, 2009 C-Pulse Improves Sunshine Heart Patients; Safety Medical's $42m Hungarian Venture; Immuron HIV Trial Recruited; Cancer Research Exits Sirtex; Acuvax Plan To Raise $5m; Anteo $1m Rights Issue; Biosignal Raises $900k	Sep 18, 2009 Pharmaxis 2nd Phase III Cystic Fibrosis Trial 'Fully Recruited'; Biopharmica's Mining Option; Federal Government's R&D Tax Credit Consultation Call; Dr Terry Cutler Appointed  CSIRO Deputy Chair	Sep 17, 2009 FDA Clears CSL Swine 'Flu Vaccine; US NIH $1.4m For Starpharma; Compumedics' China DEal; Acuvax $488k Placement; Ian Chalmers, Mark Fordree Join Fermiscan
Sep 16, 2009 Patrys' PAT-SM6 Halves Colon Cancer Metastases In Mice; Asset Realisation (Stem Cell Sciences) Delists, Departs ASX	Sep 15, 2009 Marc Sinatra's Bioguide: Genera Needs Right Paptype Partner; Phosphagenics Claims World's First Transdermal Oxycodone; Changing Avita's Image; Progen-Medigen Fight For Feb 2010; BAM Takes 13% Of Prana	Sep 14, 2009 Biotech Post $68m Profit On $464m Revenue; Norwood Abbey Turns Into Chinese Coal Company
Sep 11, 2009 CSL's Low-Dose 'Flu Vaccine's 'Robust Immune Response'; CSL Votes On $17m More Free Shares For CEO Dr Brian McNamee, CFO Tony Cipa; Healthlinx, Mater Collaborate On Ovarian Cancer; Biopharmica Invests In Oil& Gas; Pharmaxis AGM; Hunter Hall Takes 27% Of Fluorotechnics	Sep 10, 2009 Phosphagenics' Diclofenac Reaches The Parts Voltaren Can't; Mesoblast Stem Cells Repair Sheep Discs; Bionomics AGM For $15m Raising; Federal R&D Tax Credits Bill; Pfizer, Merck, GSK At Bio-Melbourne Show; IM Medical Reappoints CEO; Solagran Pleads Schultz To ASX 46% Price Jump Query	Sep 9, 2009 Chemgenex FDA NDA 'Australian First'; Bioguide Brief: Chemgenex ASX's 'Most Undervalued Biotech'; Cochlear Pays $US25m On Road to Total Hearing Implant; Prana's Mystery $6m Man; Fluorotechnics Raises $1.23m; Victoria's $500k Biotech Partnering Program; Future Fellowships; Progen Defines PG11047 Dose; Immuron, Hadasit Ready For Immunotherapy Trials
Sep 8, 2009 Sirtex's Dr Bruce Gray Wins 'No Duty To Invent' Case; Spruson & Ferguson:  IP Genie Unbottled; Bionomics Raises $12.8m, Plan To Raise $2.2m; Medical Therapies' Midkine Boosts Breast Cancer Tests; PNK Takes 31% Of Patrys	Sep 7, 2009 Benitec, China's Biomics Begin Hep B ddRNAi Collaboration; Circadian Licences VEGF Rights To Perkinelmer; Uscom Plan To Raise $1.26m	Sep 4, 2009 FDA Greenlights Cochlear Nucleus 5 Launch, Cytopia Phase I/II CYT Myelofibrosis Trial; Support For Genera's Paptype HPV Test; Uscom's US Pacemaker Patent
Sep 3, 2009 Leo Pharma Bids $348m For Peplin; Bioguide Brief: Peplin Not A 5-Banger, Any More; Fed Gov, Start-Up, Starfish $10m For Bionomics, Mimetica; Sirtex SIR-Spheres Improve Liver Cancer Treatment; Acrux Bullish On Testosterone Trial; Cathrx Euro Distributor	Sep 2, 2009 W.H.O. Licences Biodiem's LAIV For Pandemic Plan; Tyrian Delivers 500 Wheat Scanners To Bayer; Prima's South Korean Patent; Suspense Over For Heartware, OMI; Ausbiotech Course on Monte Carlo Valuations; Eastland Loses CFO, Co Sec	Sep 1, 2009 August BDI-40 Up 7%, Benitec Up 90%, Heartware 80%; Heartware, OMI Suspended On Accounts; $1m For Aust Stem Cell Centre; Unilife Nasdaq Listing; Ventracor Unplugged; Biodiem Benefits From US-Russian Collaboration
Aug 31, 2009 Clinuvel's Pre-emptive Extra Euro Phase III Trial; FDA OKs Prima Phase IIb Ovarian Cancer Trial; Biodiem Completes Phase I 'Flu Vaccine Recruitment; Unilife $13m Profit, Revenue Up 869% To $40m; Tyrian Raises $5m; CBio To Raise $6m, List On ASX, Restart Trial, Avita Loss Down 58%, Revenue Up 67% To $3m; Pharmaust Loss Down 97%, Revenue Up 25% To $4m; Benitec Japan Patents	Aug 28, 2009 UK Requires Further Halcygen Trial; Sirtex Profit Up 1406% To $18m, Revenue Up 88% To $74m; Resonance $617k Maiden Profit; Imugene $650k Maiden Profit; Stirling Invests In Drug Delivery; Uscom Revenue Up 53% To $2m, Halves Loss; Solagran Director For Bioprospect	Aug 27, 2009 Prima Explains Ovarian Cancer Vaccine; Victoria's $26m For Medical Research Facilities; Ellex $22.6m 'Goodwill' Loss, Revenue Up 16% To $58m; Cyclopharm H1 Loss, Revenue Down 1% To $4m; Medical Developments Profit Down 9%, Revenue Down 5%; Immuron's 47m Shares For Hadasit
Aug 26, 2009 Biomd Prepares Phase II Pelvic Floor Reconstruction Trial; Acuvax-Hawaii Begin Phase I Dengue Fever Trial; Advanced Surgical $1m Loss, Revenue Down 10% To $6.4m; $600k For 3 NSW-China Collaborations; Phylogica's 'Multiple Advanced Big Pharma Negotiations'; Healthlinx Backs Healthscope Acquisition	Aug 25, 2009 QRX Morphine-Oxycodone Beats Paracetamol-Oxycodone; Mesoblast's Angioblast Raises $10m; Japan Patent For Circadian-Vegenics' VEGF-C; Cellestis Record Profit Up 391% To $8m, Revenue Up 80% To $35m; Cogstate's $1.4m Maiden Profit; Three Biotechs Win $70k Comet Grants	Aug 24, 2009 Editorial: ASIC Acquires ASX Powers - Now For Transparency; Two Patrys Compounds Ready For Human Trials; Medical Therapies Cardiac Stent Euro-Patent; Human Embryonic Stem Cells Glow Red Becoming Blood
Aug 21, 2009 Biotech Daily Call To Arms For Federal Funding; Terra Rossa Injects $1.25m Into Acuvax, Closer To Hawaii; Heartware Implants 50th Patient; Oversubscribed Immuron Plan Raises $1.3m; Phylogica Appoints Ex-Psivida CEO Gavin Rezos Investor Relations Adviser; Neurodiscovery CEO Chris Moyses Resigns	Aug 20, 2009 Euro Data-Set Backs Biopharmica Anaesthesia Algorithm; Verva, Isis Collaborate On Antisense Fat Drug; Anteo, Diosion Collaborate On Antibodies; Virax Completes Phase I/IIa HIV Trial Recruitment; Probiotec Profit Up 41% To $9m; Atcor Loss Down, Revenue Up 32% To $87m	Aug 19, 2009 Biota Back In $38m Profit, Revenue Up 85%, Hunter Hall Increases To 13%; CSL Profit Up 63% To Record $1.1bn; FDA Go Ahead For Bone Phase III Osteoporosis Trial; Mesoblast's Angioblast Raises $7-10m; Peplin Completes 2nd Phase III AK Trial Enrolment; Immuron's Bioguard In HIV G-I Trial
Aug 18, 2009 Heartware Raises $6.1m More; Key Australian Patent For Labtech Microbiol Streaking; IDT Profit Down 10% To $6.4m; Impedimed CFO Role Relocates To US, Phil Auckland Resigns	Aug 17, 2009 FDA Clears Mesoblast Phase II Lumbar Spine Fusion Trial; China OKs Avita Recell, Helicon Distributor; Patrys Underwriter PNK Takes Most Of $5m Plan; Antisense ATL1101 Suppresses Resistant Prostate Tumors; Pharmaust Sells Factory, 'Will Be Debt Free'	Aug 14, 2009 Call For Commercialization Submissions; Senator Abetz: CCI 'A Farce', Bring Back Commercial Ready; Neuren Plan Raises $815k; Agenix Receives $87k China Payment
Aug 13, 2009 Phosphagenics' Option On Metabolic's AOD9604 To Rub Away Fat; Immuron Jumps 210% On Big Pharma 'Flu Talks; US Army Pays Avita $480k, Pilot Study Results; Biota Returns $20m - 11c Per Share; Viralytics 12 Patients To Go For 3 Trials; Phosphagenics Plan To Raise Up To $9m; Dia-B, Pallane Merger Dead	Aug 12, 2009 Biotechs Raise More Than $300m In 7 Months; Biopharmica Up 10-Fold In 3 Days, Share Plan, Spin Out; Paul Keating's Brain Resource $4.2m Maiden Profit; Acuvax's Hawaii Wins $3.5m Encephalitis Grant; Genesis Raises $380k; Unilife Begins US Syringe Production	Aug 11, 2009 Heartware Raises $66m, Cherry Picks Ventracor; Cochlear Record Profit Up 13% To $130.5m, Revenue Up 15%;Xenome Collaboration On Receptor Modulators; Pallane's Winteray Welshes On Dia-B Deal; Immuron Prepares Animal, Human 'Flu Studies; Labtech Profit Down, Royalties En Route
Aug 10, 2009 Vale Living Cell's David Collinson; Astrazeneca Dumps Biota RSV Drug; Biota LANI Phase III Success; Metabolic Cuts Program, Polynovo To Stand Alone; Biopharmica Takes All Of HLS5, Develops Anti-Mitotic Drug; Sunshine Heart Trial, Placement, Rights Issue; TGA Approves Advanced Surgical Device; Agenix Raises $1m	Aug 7, 2009 Optiscan's Confocal Microscope 'Exquisite' In Neurosurgery; Resmed Profit Up 33% To $175m; Bio-Melbourne Finding Grants	Aug 6, 2009 Fermiscan, Prof Veronica James Await Appeal Decision; Neurodiscovery Signs $520k Deal
Aug 5, 2009 Mesoblast's Angioblast Begins US Cardiac Stem Cell Trial; Editorial: Ausbiotech, Aspermont And Independent Journalism; Genesis' $1m RNAi Collaboration; Novogen Licences NV-128 To Marshall Edwards; 'Key' Prana Patent; Prima EGM Dissent	Aug 4, 2009 Immuron's Cow Colostrum Kills H1N1 'Flu Variant In Mice; Biotron Completes Hep C Trial Dosing; Progen Sues Medigen Clique; Healthlinx: 'Ovplex Superior Ovarian Cancer Test'	Aug 3, 2009 July BDI-40 Up 10%, Biota, Prana, Novogen, Labtech Up >50%; Optiscan's New Hoya-Pentax Deal; US FTC Kills Thoratec's Heartware Bid; Starpharma's Vivagel 'Active To 24 Hrs'; Dia-B Asks Winteray To Underwrite 'Substantial Shortfall'; Benitec Appoints Fermiscan's Dr Peter French CSO
July 31, 2009 Polartechnics No Cash, Voluntary Administration, Suspension; Biosignal Goes To The Movies, Nasdaq Notice On Commonwealth Bio; Benitec Raises $215k; Tyrian Rights Issue To Raise $5m; U of Sydney Exits Medical Therapies; Running On Empty: Bone, Neuren, Incitive, Fluorotechnics, Giaconda, Stirling, Safety Med	July 30, 2009 US FTC Challenges Thoratec Heartware Takeover; Prima Applies For US Phase IIb Ovarian Cancer Trial; Healthlinx Up 280% On Ovarian Cancer Test CE Mark; Ondek's Prof Barry Marshall Wants $10m For H Pylori Vaccine; Living Cell Raises $4.2m	July 29, 2009 Bioguide Brief: Dia-B, Pallane Fully Underwritten, Not; Cogstate's 1st Cash Positive Year, Revenue Up 122% To $8.4m; Cyclopharm, Macquarie Prince Alfred Joint Venture; 4Cs, Trading Halts
July 28, 2009 OMI: 'From Bleeding Edge To Leading Edge'; Impedimed: Nth Carolina Specifies Cover; Uscom's Maiden Cash Flow Positive Quarter; Pallane, Dia-B Shortfall; Michael Spooner Replaces Dr Richard Opara At Hawaii; Victoria, Smorgon Prizes; Deck Chair Takes 17% Of Incitive	July 27, 2009 Two Sunshine Heart Patients Complete 3 Month Tests; Imugene Swine Flu Vaccine For Swine	July 24, 2009 Biosignal Sells IP For $3.2m; Fermiscan Breast Cancer Trial In Egypt
July 23, 2009 Tissue Therapies' Trouble In Toronto, New Improved Vitrogro; Peplin Begins 2nd Non-Head Lesion Phase III Trial; Mesoblast Applies For Bone Fracture Trial; QRX Starts Phase II I-V Moxduo Pain Trial; GSK Triples Relenza Capacity, Pays Biota $9m Royalty	July 22, 2009 Bioguide Brief: Prima's $25.5m Convertible Note; CSL Begins Swin Flu Vaccine Trial; Virax HIV Drug 'A New Mechanism'; Curiouser & Curiouser - ASX Queries IDT Governance	July 21, 2009 Prima's $25.5m Convertible Note; Compumedics Profit Up 217% To $2.4m; Stirling's Management
July 20, 2009 Stirling Journal On Herbal TB/HIV Remedy; Phosphagenics Cosmetics Deal With Metier Tribeca; Genera Passes TGA Audit; Aust Stem Cell centre 'Supports' Dr Livesey, Dr Traianedes; Avita's $5m Fortrend Draw-Down Facility	July 17, 2009 Taiwan Wins 3 Progen Seats, But Not Control; China Pays $91k, Not $2.8m; Narhex Prepares To Resume Operations; OMI $63m Deal, $6m Raising; Immuron's Dr Zeil Rosenberg Resigns	July 16, 2009 Polartechnics Merger Buried, Fermiscan Loses M-D, CFO; Biomd Up 129% On Safety Data; Cogstate Profits From Weaker Dollar; Prana: PBT Improves Age-Related Cognition In Mice
July 15, 2009 Clinuvel's Afamelanotide 'Effective In Solar Urticaria Pilot Study'; OMI Revises Revenue Forecast	July 14, 2009 Bioguide Brief: Delist Or Not Delist; CSIRO, Avexa $2m Hep C Collaboration; Benitec, China's Biomics Hep B Collaboration; Cochlear Expects Lower Record Profit; Medigen Takes 8.5%, CCH 5% Of Progen; Biodiem Appoints Julie Phillips CEO	July 13, 2009 US Study: Uscom Can Cut ICU Fluid Use By 50%; Acuvax Adelaide Subsidiary; Pharmaxis Quits Nasdaq; Biosignal Related-Party IP Sale; Norwood Trims Sails For Trading
July 10, 2009 New Analysis Backs Prana Alzheimer's Data; Dream Pharma Sells Acrux's Ellavie In South Africa; Nanosonics Approved In Israel, FDA Review; Cathrx Raises $6.9m; Neuren Plan To Raise $2.3m Evado Software In Asia	July 9, 2009 Vistech Has $US4m For R&D; Viralytics Part Converts Note, Places 700k Options; Solagran Appoints Justyn Stedwell Company Secretary	July 8, 2009 Novogen's Phenoxodiol 'Kills Proliferating T-Cells'; Living Cell's Pig Brain Cells 'Help Prevent Hearing Loss'; Monash Uni 'Proves' Obesity Type 2 Diabetes Link; Sirtex Profit Up 640%; South African Patent For Biomd Patch; Dia-B Shrinks Shares 20:1
July 7, 2009 CSL, Cancer Biology Test AML Drug; Peplin Phase III Recruited; Medical Therapies Raises $550k; Dr Bruce Gray's Sirtex Coup Fails, Again; NSW $17m Land-For-Cash-For-R&D Deal	July 6, 2009 Living Cell Opens Russian Subsidiary; Ex-Immuron CEO Dr Zeil Rosenberg Claims $500k	July 3, 2009 Bioguide Brief: Progen - A New Train Coming? Dr Micah Atkin, Fermiscan Win Next Big Thing
July 2, 2009 Bionomics Selects Dose For BNC105 Renal Cancer Trial; 'Jilted' Polartechnics Takes 22% Of Fermiscan; Living Cell Opens Pig Breeding Facility; Acorn Exits Neuren, Reduces In Cytopia	July 1, 2009 Year To June 30 BDI-20 Up 32%, Biotechs Raise $30m/month; Neuren Jumps 170% On US Army $17m; Progen Changes Board, Licences PI-88, Keeps CEO Justus Homburg; $30m Unilife Sanofi-Aventis Deal; Safety Medical Sells Bagot Press; Viralytics Options Raise $915k; CE Mark For Cathrx Loop Catheter	June 30, 2009 Bioguide Brief: Strapped For Cash And The Wedding's Off; Ferrier Hodgson: Ventracor investors 'Get Nothing'; USPTO Contests Genetic Technologies' Patent; Impedimed Raises $7m; Pharmaxis Plan Raises $7.2m; Dr Cherrell Hirst Joins Tissue Therapies; Lawrence Gozlan Joins Avexa
June 29, 2009 Report Kills Fermiscan-Polartechnics Merger; Phosphagenics Transdermal Opioid Passes 1st Safety Test; Dia-B Investors Back Pallane Takeover; Chemgenex Quits Nasdaq, Downsizes Board; Prima Plan Raises $165k Of Expected $1m	June 26, 2009 Euro Dataset Hopes For Biopharmica Collaboration; Eastland Raises $3.2m; Advanced Surgical Signs Distributor; Goodnight Stem Cell; Stirling Hopes To Buy Milpharma, Securites & Investment Takes 19%' Dia-B Pallane Offer Extended One Month	June 25, 2009 Editorial: ASX In Wonderland III - Corporate Regulation; Bionomics Begins Phase I BNC210 Anxiolytic Trial; Polartechnics Takes 21% Of Fermiscan; CEO Sze Wee Tan Quits Rockeby
June 24, 2009 NZ Approves Living Cell Xenotransplant Type 1 Diabetes Trial; Mesoblast Claims Early Bone Marrow Transplant Success	June 23, 2009 Cytopia Applies For US Phase I/II CYT387 Myelofibrosis Trial	June 22, 2009 Bioguide Brief: Dia-B, Pallane & A Flea In The Ear; Incintive Changes Horse From Bromelain To V-Patch; Ventracor Administrators Sale Fail - Liquidation; Acrux Signs 1st Menopause Spray Euro Licence; Stirlin Word-Of-Mouth Mongolian Sales Growth
June 19, 2009 CSL Evaluates Phosphagenics' Transdermal Technology; US Court Tells Vivus To Start Acrux Trial; Living Cell 3 Months To NZ Xenotransplant Trial; Agenix Asks Investors To Find $1m	June 18, 2009 Editorial: Biotechs, The Law & Matters Of Principle; 2nd EU Orphan Status For Clinuvel; Antisense's ATL1101 Enhances Prostate Chemo; Novogen's Closed Phase III - Results In 6 Months; Wilson HTM Takes 9% Of Cathrx; Verva Completes $2m Funding	June 17, 2009 Cathrx Human Trial Of Irrigated Ablation Catheter; Virax Half-Way In HIV Trial; Farjoy Takes 15% Of Clover Corp; Immuron Plan To Raise $900k
June 16, 2009 Pharmaxis: Bronchitol Reduces Cystic Fibrosis Exacerbations; Ventracor Winding Up, Directors Go; Psivida Drug Useful For More Indications; US, Australian Patents For Cytopia Compounds; Cathrx Signs Corizon; Impedimed Wins UK Breast Cancer Clinic	June 15, 2009 Patrys Animal Trial Paves Way To Human Anti-Cancer Study; US Patent For Fluorotechnics, Office Move; Compumedics Germany Signs $300k Contracts	June 12, 2009 It's Over: Cephalon Takes Arana; Polartechnics Offers 3-For-2 Share Offer For Fermiscan; Viralytics $7.4m Note For Cavatak; QIC Quits Tyrian
June 11, 2009 Proof-Of-Concept For Biota's Human Rhinovirus Challenge; Chemgenex Drug Extends Patients' Lives, Mechanism Of Action; Fermiscan Appeals Inventor Case; Virax Licencee Transgene In FDA Phase III Trial	June 10, 2009 Biomd: Independent US Validation Of Adapt; Progen Board Spill; Biosignal CFO Robert Vickery Last To Leave; German Dispute Over For Genetic Technologies	June 9, 2009 CSL Quits Talecris, Cites US-FTC; FDA Requires Extra Peplin Phase III Trial; Chemgenex's Omacetaxine Effective For Multiple Resistant Leukemia, Kills Stem Cells
June 5, 2009 Cytopia Loses Novartis JAK3 Funding, Cuts 18 Staff; Fermiscan Loses Dr Veronica James Case, $1.4m Costs; $83m Federal Innovation Fund Opens; Linkage Grants	June 4, 2009 Pharmaxis Raises $47m; Acrux South Africa Ellavie Deal; Avexa Picks Low-Dose ATC For Phase III HIV Trial; Stemcells Inc Shuts Down Stem Cells Australia; Sirtex' Bruce Gray Rolls Board Dice, Again	June 3, 2009 Nanosonics Launches Trophon In Europe; Compumedics 'Grael' Wins Powerhouse Gong; Bone Loses M-D Troels Jordansen
June 2, 2009 Sirtex SIR-Spheres 'Significant Benefit' To Cancer Patients; Chemgenex: More Positive Omacetaxine Data; Biopharmica, Laing Screen For Floppy Baby Syndrome; Acrux: Rivals Woes Broker Reports Push Price 18%; Eastland Notes Raise $1.75m	June 1, 2009 Six Months Of Biotech Growth - BDI-20 Up 93%; Cepjalon Has 80% Of Arana; Immuron Hadasit, Placement EGM; Viralytics' $US6m Note Impacts Options Offer; Box Hill Bio-Skills Courses	May 29, 2009 Bioguide Brief: Dia-B Pallane Merge For '$100m' Viral Test Co; Bionomics Phase I BNC105 Cancer Trial 'Shows Safety, Some Efficacy'; US Pays CSL $230m For Novel H1N1 Vaccine; Australia Ups Relenza Stocks; Immuron Cuts US Costs
May 28, 2009 US FTC Stalls CSL-Talecris $US3.1bn Deal Five Months; Capital Group Takes 11% Of Cochlear; Biosignal Directors Lodge ASIC Complaint; Impedimed Raises $5m, $7m To Go; Pallane To Raise $12.5m For Diagnostic	May 27, 2009 US Army's $2m Takes Avita Through FDA; Chemgenex's $8.4m  Takes 5-Month Total To $104m; Benitec Shortfall Raises $37k; Biopharmica Wins $50k Melanoma Grant	May 26, 2009 Optiscan Sees Light At The End Of 2nd Gen Scope; Cytopia, CRC Identify Focal Adhesion Kinase Target; Benitec, CSIRO Appeal USPTO
May 25, 2009 US FTC Blocks $3.1bn CSL-Talecris Deal; Patrys Antibodies For Cancer Trial; Cogstate $1.9m Trial, Revenue Up; Biodiem Licences Flu Technology To WHO	May 22, 2009 Progen: The Sequel - Taiwanese Call Board Coup; Starpharma Raises $7.1m; Living Cell Cancels Raising; Prima EGM, Turnbulls And Alpha Securities; Fermiscan, Polartechnics Delay	May 21, 2009 Bionomics Anxiety Drug Approved For Human Trial; Biosignal Founder, CEO Prof Peter Steinberg Resigns; Sirtex Free of Dr Bruce Gray, UWA Case; Bioguide Brief: What Gray Case Means For Research
May 20, 2009 Cephalon Has 50.4% Of Arana, Wants 90%; NZ Patent For Biopharmica's Cortical Dynamics; Virax Raises $300k; Stirling's 2nd Priceless Independent Report - More ASX In Wonderland	May 19, 2009 Novogen Jumps 115% On Ex-Chair's Blog; Genera Raises $3m, Aust Ethical On-Board; Cephalon 1% From Taking Arana; Atcor Claims 70% Sales Growth	May 18, 2009 Peplin Non-Head Phase III Clears 67% Lesions; Progen's Nth American PI-88 Partner; Bioguide Brief: Verva, Small Holders And The Unlisted Space
May 15, 2009  Verva Votes On QBF Control, $2m Raising, Directors; Universal Bio Signs New Deal With J&J's Lifescan; Sunshine Heart To Raise $5-8m	May 14, 2009 Mesoblast Claims Early Heart Failure Stem Cell Success; Optiscan Raises $500k, New Zeiss Deal, Board Changes; FDA Accepts Pharmaxis Aridol Application; Metabolic Appoints Laurent Fossaert Polynovo CEO; Stirling Adds AIDS To TB, Swine Flu Immunoxel 'Success'	May 13, 2009 Budget 2009 Surprise: Far More Than Expected; Budget Summary, Bioguide, Senator Carr, Ausbiotech, Bio-Melbourne; Becton Dickinson Tyrian TB Test Fee Funding; Nanosonics Submits FDA Application
May 12, 2009 Probiomics: Probiotic Bacteria 'Boosts Flu Vaccine'; Polartechnics Withdraws 10-Fold Sales Projection; Acrux: Analysts, Rivals Issues Pushed Price; Biosignal Appoints Tim Boyd Director	May 11, 2009 FDA Accepts Alchemia, Dr Reddy's Fondaparinux Application; Starpharma, Elanco Animal Health Deal; US BIO Backs Ausbiotech Call For Funds; Senator Abetz Urges Government To Keep Comet; China Pays Agenix $134k	May 8, 2009 Resmed Record Revenue In March Quarter; Prof Graham MacDonald Chairs Australian Stem Cell Centre
May 7, 2009 Editorial: Biotechs Beware - Vulture Capitalists Are Circling; Fed, Vic Governments Launch $1bn Cance Centre; Empire II - New Directors	May 6, 2009 Empire Strikes Back: Biosignal Directors' Cut; Goodnight Portland; Avexa CEO Dr Julian Chick Buys 595k Shares	May 5, 2009 Living Cell: '2 Of 7  Type 1 Diabetes Patients Insulin-Free'; USPTO Withdraws Benitec Objections; Benitec Raises $1.1m
May 4, 2009 Pharmaxis Bronchitol 'Improves Cystic Fibrosis Lung Function'; J&J's Tibotec Option On Avexa HIV Deal; Biota: GSK Ups Relenza Production; OBJ's Jeffrey Edwards Sells 1.5m Shares	May 1, 2009 April BDI-20, BDI-40 Up 18%, It's Safe To Go Back Into Biotech; CE Mark For Cathrx Catheter; Progen's Stephen Chang Sells 600k Shares; Pharmaust Cash-Flow Positive; Biomd Completes $860k Placement; Living Cell Loses Dr Robert Caspari	April 30, 2009 Avexa Rights Issue Oversubscribed, Raises $17m; CSL Develops Swine Flu Vaccine; IB Fund Up 21% In 9 Months; Phosphagenics' Better Acne Treatment; Editorial: Appendix 4Cs And The Real World
April 29, 2009 QRX Explains Dual Opioid's Lower Side Effects; Tissue Therapies: 'Outstanding' 2nd Toronto Patient Results; Stirling Immunoxel 'Good For Swine Flu As Well As TB'	April 28, 2009 Fermiscan v Inventor Prof Veronica James; Editorial: Who Breaks A Butterfly On A Wheel? Mesoblast Begins Cervical Spine Fusion; Biosignal Takes 3 Empire Directors For $120k; Prima 1 Month To Ovarian Cancer Trial	April 27, 2009 Bioguide: Big Pharma Wrong - Peplin A 5-Banger; Biota Jumps 90% On Swine Flu; Biota's Dr Jim Fox - Government Must Invest In Education; Progen Buy-Back Undersubscribed; Heartware Claims One Year 86% Survival; QIC Quits Chemgenex
April 24, 2009 Genetic Techno Trial Date Set; Orbis Up In Chemgenex, QIC Down; OBJ Director Dumps 5m Shares	April 23, 2009 Relenza Earns Biota $32m; Nasdaq Suspends Progen; US Patent For Xenome Pain Peptide; Polartechnics Signs East Euro Deals	April 22, 2009 Bionomics' BNC105 'Very Effective' For Throat Cancer; Progen EGM Backs Buy-Back; Circadian Compound Boosts Chemo In Mice; Neuren Cancer Co Price Halt

 

April 21, 2009 Hadassah Takes 19.9% Of Immuron For Antibody Work, Antibody Safe Status; Neuren Halt for 1320% Price Jump; Sunshine Heart Implants 1st Two Aorta Cuffs; Dr Paul MacLeman Exits Hatchtech For Genetic Technologies; Progen's Stephen Chang To Sell Shares; Chemgenex Rights Issue To Raise Up To $7.4m	April 20, 2009 Bioguide Brief: Blessing Polartechnics-Fermiscan Marriage; QRX Moxduo 'Fewer Side Effects Than Components'; Entrusting Metabolics' Board With Polynovo; Viralytics Ups Phase I Cancer Trial Dose; Novogen's NV-128 Stops Cancer Cell Differentiation; Progen Technology 'Inhibits Tumor Growth'	April 17, 2009 Polartechnics-Fermiscan Merger; Euro-Partner To Fund Chemgenex Flying Solo In US; Review Delays Living Cell NZ Diabetes Trial; Agenix: China Deal Back On Track Over Abyss; Neuren ASX Query; Avexa 39% Price Query; Fluorotechnics Raises $1.2m; Incitive $784k; Medical Therapies $700k
April 16, 2009 Stirling Claims '100% Success' Against TB; Neuren 420% Share Price Query; Prima 75% Share Price Query; Kinetic Under 5% Of Nanosonics; Acorn Takes 12% Of Starpharma	April 15, 2009 Novogen Closes Phase III Cancer Trial To Conserve Cash; Atcor Wins $1.2m Contracts; Acuvax Sells Resprotect Stake	April 14, 2009 Editorial: Why Is There Good News? Peplin Gel To Be 'Standard Of Care'; Japan OKs Cellestis In-Tube TB Test; Vivus Has 30 Days To Set Acrux Phase III Trial; Phylogica, Aegis Work On Intranasal Phylomers
April 9, 2009 Chemgenex Raises $10m; OK For Psivida Phase III Trial; FMR Under 5% Of CSL; Victoria Opens $153m Regenerative Medicine Unit	April 8, 2009 Genera HPV Test Equals Pap Smear; Living Cell: 'Pig Cells Safe In Primates'; Novogen's GLYC-101 'Effective For Wounds'; OMI 100% Revenue Growth; Telstra Super Takes 5% Of Metabolic	April 7, 2009 Bioguide: Prana And The Difference A PBT2 Deal Would Make; Starpharma Raises $4.6m; Entrust Takes Dr Tony Ward's 19.8% Of Metabolic
April 6, 2009 Living Cell Diabetes Patient 'Insulin Independent'; Universal Pleads Schultz To 62% Price Hike Query; Unilife Moves To Pennsylvania; Chemgenex Halt, Denies AFR Report	April 3, 2009 Incitive Licences Pineapple Stem Animal Health To Peptech; Dr Tony Moore Takes 19.8% Of Metabolic; Manufacturing Halts CBio Trial, $1.5m Raised; Evado Provides Staff With Trial Software	April 2, 2009 Crisis, What Crisis? 'Struggling' Biotechs Raise $370m-$500m; Study 'Validates' Prana Alzheimer's Strategy; Stem Cell Sells Assets for 2.65m Stemcells Shares; Avita Sales Up 72%; Incitive Raises $784k; Progen Shrugs Off Coups - Back To Work
April 1, 2009 March BDI-20 Up 20%; 4 Months Of Growth; Polartechnics 'Friendly Merger'; Cephalon Takes 23% Of Arana; Pharmaxis Completes 1st Phase III Dosing; Compumedics' $400k German Contract; Biomd Raises $426k; Solagran's Peter Stedwell Dies	March 31, 2009 Franklyn Brazil Quits Metabolic; Atcor's Sphygmocor 'Predicts Pre-Eclampsia'; Heartware's 1st Commercial Sales	March 30, 2009 Bioguide Brief: The Progen Prize Goes To .... Medigen? Dr Wolf Hanisch Appointed 3rd Director; Biota Partner Ready For Japanese Market; Mesoblast Raises $11m; Nanosonics Begins Sales; Bio-Melbourne's Call To Alms
March 27, 2009 Chemgenex Drug '4-10-Fold In Vitro Stem Cell Efficacy'; Taiwan Wins Progen-Cytopia EGM; Thoratec's Heartware Bid Delayed; Acorn Takes 8% Of Pharmaxis	March 26, 2009 Benitec, CSIRO Continue USPTO Fight; Prima's 2nd Euro Patent For CVac Ovarian Cancer Therapy; Uscom Takes Cardiac Monitor To China	March 25, 2009 Many An M&A Slip Between Arana's Cup, Cephalon's Lip; Biopharmica Characterizes Protein Expression; Copulos' $3m Healthlinx Line; Avexa rights Issue To Raise Up To $15m
March 24, 2009 Monash Uni, Synchrotron 'Solve' Cytopia's JAK1 Protein; Avexa Begins 16-Week Phase III HIV Analysis; Healthlinx Plan Raises $144k	March 23, 2009 Acuvax Hawaii Biotech Execs In Australian Roadshow; Neurodiscovery $540k US Deal; Optiscan Kills 2nd Hoya Deal; Progen's Post-Buy-Back Program	March 20, 2009 Novogen's NV-128 Kills Cancer Stem Cells In Vitro In 15 Mins; Avexa's Alan Boyd Resigns
March 19, 2009 Ventracor In Administration; Starpharma Completes Vivagel Longevity Study; Alchemia-SDP Deal; Ausbiotech: $83m 'Too Little Too Late'; Bio-Melbourne Network: '$83m Won't Go Far'; GBS Raises $122.5m; Acuvax Trial Enrolled	March 18, 2009 Federal $83m Innovation Fund; Ausbiotech Response; Editorial: A Pittance Is Better Than Nothing; Senator Eric Abetz Marks Labor's Card	March 17, 2009 Graeme Kaufman: Mesoblast A $1.65 Buy; Xceed Appoints Stephen Belben
March 16, 2009 Avexa: 87% Of Phase IIb HIV Patients 'In Good Health'; Cytopia's Andrew Macdonald: Progen Board Should Quit; Solagran Raises Ropren Drops Dose	March 13, 2009 Alchemia Heparin ANDA Filed To FDA; Psivida Eye Insert Safety Data; Tissue Therapies Wins Mel Bridges As Director; Nusep Suspended For Nxcen's Longer Lasting Listing	March 12, 2009 Ventracor Heart Pump Completes US Trial; Asset Selection Takes 5% Of Cytopia; Benitec Cancels CSIRO Talks; Biopharmica Wants Partner For New Cancer Drugs
March 11, 2009 Fortrend's $12m Puts Prima Back On Track; Bioguide Brief: Is That A Whiff Of Cash In The Air; Prana's PBT2 Repairs Mouse Synapse Damage; Hitachi Takes option On Fermiscan Test	March 10, 2009 Progen $40m Buy-Back Cuts Across Cytopia Plans; Most Progen Investors Don't Vote; Italian Study 'Confirms Fermiscan Test'; Solagran Contributors Forfeit $1.1m Shares	March 9, 2009 Progen Kills Avexa Deal; Bioguide Brief: Progen Cops A Kicking; Arana Phase II Meets Endpoint; Pakistan Buys 100 Polartech Cancer Consoles; Cathrx Cuts Costs
March 6, 2009 Peplin Gel Reduces 85% Of Head Lesions; Prima Renews CVac Treatment; Opes Prime May Get 40% Back - Or Not; Progen Pays For Proxies; Metabolic Loses Polynovo's Dr Ian Griffiths	March 5, 2009 Cytopia Injunction Over Progen-Avexa Merger; Avexa's Dr Julian Chick: 'We'll Do A Deal For ATC'; Hunter Hall Takes 30% Of Sirtex	March 4, 2009 Tissue Therapies' $1.8m 'Exceeeds Expectations'; Key Novosorb Patent; Neil Leggett Fraud Case Adjourned
March 3, 2009 Stemcells Inc Buys Stem Cells For $7m; Bioguide Brief: Stem Cell Sells All But Shell; KV's Woes Force Focus On Acrux; Halcygen Super-Generic Beats Original	March 2, 2009 BDI-40: Summer Shines On Biotech; Bioguide Brief: Arana And Under-10s Cricket; Arana Chair Robin Beaumont 'Very Disappointed'; Biota Loses Chair John Grant, Gains Dr James Fox; Pharmaxis Sends Aridol NDA To FDA	February 27, 2009 Cephalon Offers $329m For Arana; Stem Cell Centre Review; Cytopia Forces Progen-Avexa Delay; Ventracor Funds, TGA Talks, Suspended; Compumedics, Resonance H1 Profits Up; ITL, Pharmaust Losses
February 26, 2009 Acuvax, Hawaii Biotech West Nile Trial Safety; Stem Cell Suspended For Sale; Ellex Record H1 Revenue; Medical Developments, Cyclopharm Profits Up; Cathrx 1st Revenue	February 25, 2009 Bioguide Brief: Who Contributes To Solagran's Share Price?; Circadian, Healthscope $10m Peter Mac Diagnostic; Cogstate Maiden H1 Profit; Novogen Phase II Safe, Some Efficacy	February 24, 2009 Phosphagenics' TPM-Diclofenac '7x Voltaren'; FDA Points Bone In Right Direction; Polartechnics Share Plan
February 23, 2009 Acrux Phase II Contraceptive Trial Success; Healthlinx Anti-Fat Compound Works In Rats; Medical Therapies Wipes $1.1m Obligation	February 20, 2009 Fermiscan Buys Synchrotron Time; Cyclopharm US Sales Delayed; Heartware Lists On Nasdaq, Capital Structure; Solagran's 'Wrong' Email	February 19, 2009 Biomd $860k From A Revolutionary Cow Patch; Virax Partner's Lung Cancer Benefit; FDA Backs Medical Developments Penthrox For Vet Use; QRX Starts 2nd Dual-Opioid Trial; Cytopia Responds To Progen Meetings
February 18, 2009 RNAi Regenerates Genesis; Ventracor Regrets Deaths, Rebutts News Article; Progen Cites Obstacles To Single Merger Meeting; Polartechnics Expands Cerviscreen Use; CSL H1 Profit Up 44%; Biota's GSK H1 Profit	February 17, 2009 Suspended Gaol For Genetic Techno Brokers; IDT H1 Profit Up 9%; $50k Victoria Prize	February 16, 2009 Thoratec Buys Heartware For $429m; Bioguide Brief: Deal Hurts Ventracor; Cellestis Record H1 Profit, Dividend; Universal Bio 'Improvement Delays Launch'; Labtech's H1 Profit; Dr Stewart Washer Resonance Chair
February 13, 2009 Agenix Revives Thromboview; Novogen Tightens Belt; GSK Ups Biota Royalty	February 12, 2009 CD 200; Biotron Reduces HIV By 99%; Ventracor Completes Enrolment; Pallane Lists Through Dia-B For Virology; Solagran Blames Investors For Price Fall	February 11, 2009 Living Cell Pig Cells 'Clear Benefit' In 5 Of 6 Patients; Avexa Rebutts Cytopia's Progen Claims; GSK Boosts Biota's Japan Stocks
February 10, 2009 GBS's Dr Joshua Funder Details Funding; Ventracor Cable Failure, Suspension; Cochlear Record H1 Profit; Viralytics Starts Head, Neck Cancer Trial	February 9, 2009 Benitec HIV Therapy 'Promising'; Uscom 'Standard Of Paediatric Care'; Cytopia Turns Up Heat On Progen; Solagran's Denis Kilroy Resigns	February 6, 2009 Bioguide Brief: Progen's Wedding Choices; Resmed Record H1 Profit; Ventracor Product Trading Halt
February 5, 2009 Ausbiotech - Federal Package 'Overlooks Biotech'; Bionomics Raises $4m; Progen, Avexa Cytopia; Biodiem's Dr Andrew O'Brien Goes	February 4, 2009 Editorial: $42bn Federal Package - Nothing For Biotech; Victoria Grant Brings Brains Back; Barclays Quits CSL	February 3, 2009 Ludwig Links Inflammation To Colon Cancer, New Targets; TGA Approves Nanosonics' Trophon; Monash Malaria Discovery
February 2, 2009 BDI-40 - Life Signs Return To Life Sciences; Peplin Up 71%, Cytopia FAlls 40%; Tissue Therapies Reduces Diabetic Ulcer 29%; 1st Australian Induced Pluripotent Stem Cells; Acrux Axes Fentanyl, Evamist KV's Silver Lining; Ausbiotech Calls For Stimulus	January 30, 2009 Federal (PISG) Report: Drugs 2nd Largest Manufactured Export - Industry Endangered By Inertia; Editorial: A Once In An Economic Lifetime Opportunity; UK Relenza Order Earns Biota $18m; Euro Sales For Heartware Pump; Avita H1 Income Up 672% To $1.3m	January 29, 2009 Clinuvel FDA Trial 'Landmark Event'; Progen Chooses Avexa Over Cytopia; AVexa Loses CFO Alan Boyd; Ventracor '79% Success'; Pharmaxis Revenue Up 60%; Cathrx Applies For Stylus CE Mark; Sirtex Profit Up 627% To $16m
January 28, 2009 Cytopia's Uncapped Bid For Progen; Bioguide Brief: Cytopia A Better Partner; Cogstate Cashflow Positive; QRX Knee Pain Trial	January 27, 2009 Biopharmica Sheds CEO Dr Peter King, Directors' Fees, Diagnostic Needs Commercial Partner; Editorial: 'Federal Labor Shockingly Short-Sighted'	January 23, 2009 Progen Backs Avexa Merger, Details Unlikely Alternatives; Agenix Ex-CEO Neil Leggett Charged With Fraud
January 22, 2009 Virax $934k Share Plan To Avoid Crisis; Uscom Sells 39 Monitors In Month; FMR, Fidelity Sell Down CSL	January 21, 2009 Clinuvel: 'Positive' Phase III Results; Neuren Continues With Trust; Atcor 76% Sales Surge	January 20, 2009 Mesoblast Cells In 1st Osteoarthritis Trial; FDA Orphan Status For Chemgenex Drug; Halcygen Completes 3rd US Fungal Trial
January 19, 2009 Tissue Therapies Up 42% On Trial Results	January 16, 2009 Neuren Phase III Trial Fails; Agenix Deal Delayed; Peplin Phase IIb 'Positive Results'; Progen Coup Group Fails; Ventracor Coup Group; ASIC Charges Select's Dr Martin Soust	January 2, 2009 BDI-40 Up 3.0%, ASX200 Down 0.6%; Polartechnics Up 91%
December 22, 2008 Progen-Avexa Merger Special Edition	December 19, 2008 Bioguide Brief: Metabolic Polynovo; Viralytics Evatak Active Against Gut Cancer In Mice	December 18, 2008 Summer Holiday Editorial; Bioguide Brief: Fair Value IPOs, Cellscreen; Metabolic Takes 60% Of Polynovo; Polartechnics Healthscope Deal
December 17, 2008 Peplin's Tom Wiggans: This Isn't Cancer Anymore, Toto; ASIC Charges GTG's Geof Newing; Bionomics Anxiolytic Safe In Mice, Dogs; Starpharma- 'Dendrimer Reduces Cancer Drug Toxicity'	December 16, 2008 Peplin Phase III Enrolment Full; France Funds Avita Recell Trial; QRX Begins Moxduoir Pain Trial	December 15, 2008 Genetic's Dr Mervyn Jacobson Faces 319 Charges; J&J Boosts Universal's Output; Elanco Submits Acrux Animal Treatment To US Regulator
December 12, 2008 Genetic Tech's Dr Mervyn Jacobson Charged, Resigns; Viralytics Cavatak Kills Human Brain Tumors In Mice; Oregon Backs Cytopia For Bone Cancer, Rheumatoid Arthritis; Cellscreen's $12m Tampap HPV IPO	December 11, 2008 Investors Shun Ventracor, Cash To March; Arana Begins ART621 Rheumatoid Arthritis Trial; CSL Details $270m R&D Pipeline; Healthlinx 10-year UK Deal	December 10, 2008 Agenix Settles China Deal; Polartechnics Renews Truscreen Supplies to Inda, China; Biomerieux Launches Previ Isola With Labtech's Microstreak
December 9, 2008 Chemgenex CML '80% Complete Blood Response'; Viralytics 4th Trial Test Cavatak In Head, Neck Cancers	December 8, 2008 Healthlinx: New Cancer Marker, 2nd Test '98% Accurate'; Gene-Marking Seen In Benitec HIV RNAi Trial; Phosphagenics Delivers Transdermal Lidocaine	December 5, 2008 Progen v Coup Group: Round 2, Jan 9; Heartware Completes Euro-Enrolment, Awaits CE Mark; Biodiem 'Flu Vaccine 'May Control Pandemics'
December 4, 2008 US Race Study Backs Atcor; Starpharma Drug Active Against All Major HPVs	December 3, 2008 Ventracor FDA Market Application, Cash Update; Portland In Administration; Patrys Trials Safe From 3rd Party Cuts	December 2, 2008 Genetic Technologies Frees Breast, Ovarian Cancer Tests; Bioguide: GTG & Corporate Philanthropy; Novogen's NV-128 'Active' Against Cancer Stem Cells, Triphendiol IND to FDA
December 1, 2008 BDI-40: Close To The Bone; Bob Moses: 'Keep Progen's Cash In Biotech'; Dr Merilyn Sleigh Joins Tyrian	November 28, 2008 Huntington's A 2nd Target For Prana's PBT2; Biota Appoints Richard Hill Director; Biodiem Paid 6th $US1m 'Flu Milestone	November 27, 2008 Metabolic AGM Scuppers Polynovo Deal; Arana Earns CSL Payment
November 26, 2008 Anadis Cow Colostrum 'Flu Data; Arana Starts Phase II Rheumatoid Arthritis Trial; Unilife Appoints Senior Staff	November 25, 2008 Clinuvel Bioguide: Drug To Cosmetic And Back; China Deal Boosts Polartechnics Revenue 10-Fold; Bioprospect Chairman Jumps Before Solagran Pushes	November 24, 2008 Progen: M&A Or Wind-Up; Phylogica Acquires Dynamic Microbials; Avexa Recruits Phase III HIV 1st Arm
November 21, 2008 Progen, Medigen, $70m Cash & The $2m Milestone; Optiscan In Prostate Surgery; FDA Clears Sunshine Heart Trial	November 20, 2008 Stem Cell's 'Significant' Pfizer Deal; Benitec Loses Staff; Heartware Implants 2nd Heart Pump	November 19, 2008 Dr Mervyn Jacobson Redirects Genetic Technologies; Cathrx Starts Australian Trial; Lab Data Backs Neurodiscovery Pain Drug
November 18, 2008 Victoria Gov Funds Zebrafish Unit; Prana PBT1 Blocks Anaesthetic Patholgy In Mice; NSW Breast Cancer Institute Adopts Impedimed's L-Dex	November 17, 2008 Biota Phase III Lani Trials Ready; Cytopia Doses 1st Brain Cancer Patient; Medical Therapies Offers 4c Share Plan	November 14, 2008 Bioguide Brief: Progen's Beerworth Review On The Money; Progen Coup Group Wins EGM; Stem Cell Wins Euro-Patent Appeal
November 13, 2008 Progen To Return $30m To Investors; 5 Patrys Products Show Cancer Potential	November 12, 2008 Polish Study: Polartechnics' Superior Cervical Cancer Test; Phosphagenics, Acrux Trial NSAIDs; Stem Cell $1.1m Licence	November 11, 2008 Canada Approves Tissue Therapies Trial, WA Patients Improve; Ausbiotech Broadsides Federal Government; Progen Coup Group's Demands
November 10, 2008 Progen Investors Narrowly Miss Coup Meeting; Ellex Laser 'Safe, Effective' For Diabetic Macular Oedema	November 7, 2008 Biotech Daily Is Three; Division At Living Cell AGM; OMI Raises $503k	November 6, 2008 FDA Extends Ventracor Trial, Revenue 'A Record'; Arana Loses CEO Dr John Chiplin
November 5, 2008 Ventracor Implants 100th Euro Patient, Cannula CE Mark; Mesoblast Phase I/II Bone Marrow Trial	November 4, 2008 Pharmaust, Curtin Univ Of Technology Collaborate On Diabetes	November 3, 2008 Gloomy October: Living Cell Up 16%, Optiscan Down 67%; Adieu Apollo; FDA OK For Arana Trial
October 31, 2008 Genetic Technologies Fixes Cancer Test Prices; Giaconda Loses $40m Hope	October 30, 2008 Most Alchemia Projects On Hold; White Knight Saves Norwood Abbey	October 29, 2008 Novogen's Phenoxodiol, N128 Cancer Synergies; Biota Board Decision-Making Questioned; Advanced Surgical's 1st European Use
October 28, 2008 Alchemia Slashes 60% Of Staff; Prof Trounson's $US3bn Stem Cell Institute; Living Cell '3-5 Years To Market'; Ventracor Tightens Belts	October 27, 2008 Ventracor Bioguide: A Heart Beat Away; Stem Cell's Embryo-Free Pluripotent Cells; AusBiotech Conference Opens	October 24, 2008 Biota Chair John Grant Late Mind-Change On Vote; Hunter Hall Takes 12% Of Biota; Bioprospect Resists Solagran Coup; Fluorotechnics Raises $8m
October 23, 2008 Benitec 'Very Encouraged' By RNAi HIV Trial; Genetic Technologies' Cancer Tests Challenged; FDA Approves Alchemia Phase III Cancer Trial	October 22, 2008 Grahame Leonard Upsets Genetic Techno Spill Bid; Exclusive: Dr Mervyn Jacobson Explains; Anadis Studies Biogard For HIV	October 21, 2008 Living Cell Jumps 64% On NZ Xenotransplant Trial; US Patent For Alchemia
October 20, 2008 Fed Gov Releases Pharmaceutical Industry Report; Tissue Therapies Claims 'Exceptional' Results	October 17, 2008 Incitive Meets Rough End Of Biotech Pineapple; Cyclopharm Rights Issue For $3.2m	October 16, 2008 FDA Clears Impedimed’s L-DEX U400; Paul Keating In Brain Election; Optiscan Falls 39%
October 15, 2008 Antisense ATL1101 Suppresses Human Prostate Tumors In Mice; Genera Claims Superior HPV Test; Bioguide: Chemgenex' Pacific Gulf	October 14, 2008 Imclone Names Cancer Candidate From Circadian Target; IDT's Geoffrey Lord Buys His 2.5m 'Lost' Shares	October 13, 2008 Mesoblast Up 20% On Cardiac Trial Data; US 2nd Request To CSL On Talecris; Chemgenex Plan Raises $128k
October 10, 2008 Immugene Vaccine Protects Pigs; IM Medical Takes Heart Test To Mines	October 9, 2008 Biomd Implants 10th Bovine Heart Patch; Arana Appoints Gordon Black; Buys Back Shares	October 8, 2008 Stem Cell Licences Cambridge Technology; Ausbiotech Conference; Brainz Shuts Down
October 7, 2008 Halcygen 1/2 Dose Super Generic Matches Sporanox; Agenix Notes, Placement To Raise $800k	October 6, 2008 Nathan Drona Chairs Avexa; Impedimed's US Awareness Campaign	October 3, 2008 Impedimed Supplies US Lifestyle Co; Pharmaxis Takes 12 Abstracts To Berlin Meeting; Solagran Tightens Control Of Bioprospect
October 2, 2008 Bioguide: Phosphagenics' Very Deep Vitamin E Pipeline; Arana Superhumanizes Circadian's VEFG-D Antibody; Psivida Medidur Results 'Very Encouraging'	October 1, 2008 Grey September: Biotechs Down, Sunshine Up 80%; Pharmaxis Files Bronchitol Marketing Application; Synchrotron Rapid Access	September 30, 2008 Arana Files Rheumatoid Arthritis Drug IND; Advanced Ocular Sells Patents For $US2m; Neurodiscovery Part-Time CEO Starts On $203k
September 29, 2008 Alchemia Cancer Drug IND To FDA; Biota's Peter Molloy Appointed Viralytics Director	September 26, 2008 Norwood Immunology's Stem Cell Strategy; Review Backs Psivida Phase III Trial	September 25, 2008 Cochlear Fights Union; Sunshine Wins FDA Rebate; Xenome Begins Pain Trial
September 24, 2008 ASX Queries Director's Statements; AGM Votes On New Sunshine Chairman's 2m Options	September 23, 2008 Phosphagenics Starts Phase I Lidocaine Trial; Heartware Meets FDA Conditions; Clinuvel Begins 5th CUV1647 Trial	September 22, 2008 Vale Jeff Wassetheil Genetic Tech Board: Sack The CEO, We Walk; Police Investigate Bioprospect's Snr Sgt Tony Langdon
September 19, 2008 Editorial: Friends Of Mervyn & The Perils Of Owner-Drivers; Anadis, Tatura Milk Collaborate On Export	September 18, 2008 Dr Mervyn Jacobson Spills Genetic Technologies' Board; Biopharmica WAIMR Develop Cancer Drug; Fed Gov $60m Bio-Venture Capitalism	September 17, 2008 Cathrx Sells 1st Product; Chemgenex Raises $13m; Virax Partner Posts Positive Cancer Data
September 16, 2008 Agenix Sues Leggets For $4m; Immune Data Backs Biodiem's LAIV For 'Flu; Bionomics BNC105 Shows Anti-Tumor Activity	September 15, 2008 Agenix Alleges 'Breach Of Duty' Against ex-CEO Neil Leggett; China Grants Labtech Patent; Norwood Reformation	September 12, 2008 Virax Hit By Roche-Transgene Delay; Agenix Director In 'Impropriety' Case; Sunshine Heart Trial Approved
September 11, 2008 Viralytics 'Encouraged' By 2 Cavatak Studies; Eastland Expects Good Malaria Results	September 10, 2008 Biolayer, Prince Of Wales Collaborate On Neuro-Diagnostics; Bioguide Brief: Starpharma; Ellex German Sales	September 9, 2008 Cutler Innovation Review; Starpharma Up 60% On $100m Condom Deal; Peplin Starts Phase III
September 8, 2008 Nasdaq Sends Progen 'Deficiency Notice'; Merrill Lynch Takes 5.5% of Arana; Australian Stem Cell Centre Interim Board	September 5, 2008 Polartechnics, Genera, Healthscope Partner On HPV; Aust Stem Cell Centre Loses Board; Solagran Down 32% On Info Night	September 4, 2008 Phylogica, Cambridge Partner on Cancer; Anadis Develops HIV Therapy; Fluorotechnics IPO
September 3, 2008 Tissue Therapies Trial Shows 'Marked Improvement'; Israel Approves Anadis Trial; Spinifex Raises $12m	September 2, 2008 Stem Cell: 'World 1st True Rat Embryonic Cells'; Bioguide - Mergers; Ventracor's Peter Crosby On The Roadshow	September 1, 2008 Bio-Spring: BDI-20 Up 14.3%, Big Caps Up 29%; Bionomics Reduces Anxiety In 3 Species; FDA Okays Cytopia Trial
August 29, 2008 Agenix Requests 'Up To 2 Months' Suspension; Medical Therapies Sets Out Program	August 28, 2008 Ventracor Revenue Up 163% To $20m; Arana Completes Psoriasis Recruitment	August 27, 2008 Phylogica Improves Potency, Duration; Neuren Divests Cancer Program
August 26, 2008 Neurodiscovery Drug 'Effective In Pain Relief'; Avexa Takes Greater Control of ATC	August 25, 2008 Prima To Meet FDA For Cancer Drug; Cellestis $2.25m Maiden Profit	August 22, 2008 If Marc Sinatra Was King Of Circadian
August 21, 2008 Mesoblast Benefits From FDA Spinal Fusion Warning; Heartware Implants 1st US Pump	August 20, 2008 Anadis Spray 'Switches-Off' Flu Virus Replication; Pharmaxis Bronchitol 'Safe' At 12 Months	August 19, 2008 Peplin Appoints Tom Wiggans CEO, Raises $24m; Uscom Boosts Transplant Organs 15%
August 18, 2008 Dr Ian Nisbet Reforms Xenome For 2009 IPO; Bioguide Brief: Acrux	August 15, 2008 Schering-Plough Halts Two Acrux programs; IDT Profit Up 30% to $7m	August 14, 2008 Acrux Orion Alliance; Polartechnics Truscreen Demand Up, Results Better, US Interest
August 13, 2008 CSL Buys Talecris Plasma For $3.1b, Profit Up 30% To $702m; Starpharma Trials Vivagel's Antiviral Retention	August 12, 2008 Bronchitol Improves Cystic Fibrosis Lung Function; Acrux Expands KV Deal; Mesoblast Grows Cartilage In Sheep	August 11, 2008 Tissue Therapies Treats 1st Patient; Biota Challenges Common Cold
August 8, 2008 Sth Africa Approves Virax HIV Vaccine Trial; NZ Patent For Benitec RNA	August 7, 2008 CEO Interview: Bionomics' Dr Deborah Rathjen; Biotron Begins Hep C Human Trials	August 6, 2008 Monash Opens $11m Monoclonal Antibody Facility; Mesoblast Claims Long Bone Stem Cell Success
August 5, 2008 FDA Backs QRX Phase III Plan; Antisense: ATL1102 Different From Tysabri; Comment	August 4, 2008 Antisense In Tysabri Trading Halt; Journal Backs Uscom For Paediatrics	August 1, 2008 July BDI-20 Beats All Ords, Again: Heartware Up 54%, Progen Down 55%
July 30, 2008 Lancet Publishes Prana Alzheimer's Efficacy Data; Impedimed Sales up 109%	July 29, 2008 Avantogen Wants Funds For Hawaii; Clinuvel's 1st US Approval	July 28, 2008 Agenix China's Heads To Roll
July 24, 2008 Cytopia Bioguide - Flying Under The Radar; Biota's Relenza Royalties Tumble; Landlord Shanghais Agenix	July 23, 2008 Progen Halts Phase III Cancer Trial; Bioguide Brief; Antisense Competitor Triples Sales; Bionics Conference, Bionic Eye Development	July 22, 2008 Living Cell: 'Benefit In All Type 1 Diabetes Patients; Anadis Renews Tel Aviv IBD Trial
July 21, 2008 Biota Loses GSK Court Gamble; Bioguide Brief; Advanced Surgical Device Used in Cardiac Surgery	July 18, 2008 Metabolic Becomes Polynovo With $18m Cash; Editorial: A Marriage Made In Bio-Heaven	July 17, 2008 Astrazeneca's Medimmune Evaluates Norwwod Vaccine; Viralytics New Directions; Prana Big In Chicago
July 15, 2008 Proteome Halts Prostate Ca Test; Circadian Takes 100% of Vegenics	July 11, 2008 Genetic Techno Enforces Breast, Ovarian Ca Test Rights	July 10, 2008 Graeme Kaufman: $400m Fund Delayed, But Still Bullish; Mesoblast Stem Cells for Eye Disease
July 9, 2008 Tissue Therapies To Start Perth Trial; Starpharma's Vivagel for Vaginosis	July 8, 2008 Giaconda Halts Hep C Trial	July 7, 2008 Hunter Immunology Applies for FDA Phase III COPD Trial; Psivida Starts Phase IIb Pancreatic Ca Trial
July 3, 2008 Avita Close To China Registration; Medical Therapies Buys Midkine Assets	July 2, 2008 Progen Spins Out Pharmasynth; TGA Approves Safety Medical Pen Cap	July 1, 2008 June BDI-20 Beats All Ords; Chemgenex Submits Non-Clinical NDA; Sanofi-Aventis Pays $16m For Unilife Syringe

 

June 30, 2008 Antisense, Teva Positive Phase II MS Data; Neuren Expects Results Early; Bioguide Briefs - Neuren, Antisense; Biolayer Parkinson's Test; Avexa Has 12 Months Cash	June 27, 2008 Biopharmica Screening Yields 43 HLS5 Cancer Leads; Intersuisse Fund Takes 4% Of Sunshine Heart; Psivida Medidur Efficacy, Safety Data; FMR, Fidelity Drop 3% In Cochlear	June 26, 2008 Living Cell Awaits NZ Xenotransplant Approval; Karmelsonix To Market Through Pharmacies
June 25, 2008 Living Cell Shows Pig Insulin In Patient's Blood; Peplin Doses 1st AK Patient; Fermiscan Claims 84% Accuracy In Breast Cancer Hair Test; Nanosonics' TGA Application; Goodbye Clinical Cell, G'Day Avita	June 24, 2008 Opposition, Industry Protest Axing Commercial Ready; Acrux Begins Phase III Testosterone Trial; Viralytics Completes Phase I Cancer Dosing	June 23, 2008 Alchemia's Synthetic Heparin Delayed; Novogen Licences Patent To Spanish Fleet; Apollo Board Spill Call; Compumedics Chairman David Burton To Sell Down
June 20, 2008 FDA Approves Pharmaxis' Phase III Bronchiectasis Trial; Metabolic Shuts Programs, Looks For Acquisitions; Acrux Ross Dobinson Buys Opes Prime Shares; Genera Supplies Gribbles HPV Test; IM Medical Loses CEO Tommas Bonvino	June 19, 2008 Bionomics' Multiple $50m Merck MS Deals; NSW, Vic Back Stem Cell Research With $550k; Vic-Calif Stem Cell Alliance; Bone Licences Osteoporosis Product To Korea's Hyundi; Optiscan Appoints Dr Jim Fox Director	June 18, 2008 Victoria Buys $100m Bio-Supercomputer; Stem Cell Licences Green Fluorescent Protein Technology; Apollo Sells Protein Reagents
June 17, 2008 Chemgenex Efficacy In 2nd Leukemia Indication; Vic-NZ $30m Fund; Pharmaxis Bronchitol Compassionate Use; Optiscan Raises $3m; FDA Allows Halcygen IND Application	June 16, 2008 Howard Florey Imaging Detects Early Huntington's; Cellestis Expects $2m Maiden Profit; Medical Therapies EGM Backs Midkine, CEO Options; Fermiscan Buys Sydney Breast Clinic	June 13, 2008 Boss Interview: Mesoblast's Prof Silviu Itescu; Bioguide - Circadian Changes Its Rhythm; Agenix Sends Thromboview To US; Kinetic Takes 5% Of Nanosonics
June 12, 2008 Impedimed: Bioimpedance Best Lymphoedema Tool; Pharmaxis Completes 12-Month Safety Extension; Peter Mac Shows Denosumab Improves Giant Cell Tumors; Rockeby Hangover Pills For China	June 11, 2008 Circadian Becomes VEGF Cancer Drug Company; Halcygen Anti-Fungal May Have Anti-Tumor Action; Ethics OK For Clinuvel Phase II Trial; Genera Falls In 1st Day Trade; Sunshine Heart Raises $5.4m	June 10, 2008 Peplin Halts US IPO, Buys $7m Neosil, Prepares Phase III Trial; Chemgenex Buys Omacetaxine's Euro-IP; Data Committee Clears Novogen Phase III Ovarian Cancer Trial
June 6, 2008 Benitec Detects RNAi Markers In HIV Patients' Blood; EGM Backs Clincial Share Consolidation, Name Change; Psivida Votes For US Move; Pharmaust EGM To Sell Commonwealth Biotechnologies	June 5, 2008 FDA Clears Mesoblast, Angioblast Phase II Cardiac Trial; Living Cell Adds Higher Dose To Diabetes Trial; Arana Completes 2nd CSL Project	June 4, 2008 Starpharma Bioguide: Much More Than Vivagel; Avexa, Targetdrug Develop Hep C Drug; Avita Breathes Life Into Clinical Cell; Atcor's $1.15m Contract; Prima EGM Backs New Board; Nanosonics Appoints David Radford CEO
June 3, 2008 Sirtex Sir-Spheres Study 'Confirms Benefit'; More Chemgenex Phase II/III Trial Data; Biosignal Raises $400k; Living Cell 1st NZ Company On OTCQX; Gun Leo Khouri Take 14% Of Bioprospect	June 2, 2008 May Top 40 Down 1.2%, Heartware Up 39%; Biosignal Tests Anti-Microbial On Crops; Prima Hits The Road For CVac	May 30, 2008 Bioguide Update - Progen; Karmelsonix Sells 1st Australian Pulmotracks; Progen Compounds 'Inhibit Cancer Target In Vitro'
May 29, 2008 Federal Government Rejects Ausbiotech Call To Reinstate Commercial Ready Grants	May 28, 2008 Proteome, Agilent High-Tech Contra Deal; Fermiscan Pays $5.5m For Sydney Breast Clinic; CBio, Novo Nordisk Deal; Biota, GSK Trial Postponed; Agenix Co Sec Neil Leggett Replaced	May 27, 2008 Neuren Cash Burn Query, US Army Funds 'Confirmed'; Bone Appoints Leif Jensen Chairman
May 26, 2008 CSL's Dr Brian McNamee Heads Industry Review; Biolayer Replaces CEO; Bio-Melbourne Appoints Michelle Gallaher CEO; Copulos Takes 19% Of Healthlinx	May 23, 2008 Heartware Raises $30m: Underwriter Halts Benitec $5.1m Rights Issue; Brainz Cash Burn Review; Bell IXL Takes 9% Of Life Therapeutics, Board Spill	May 22, 2008 Stem Cell's Inhibitor Media For Purer Cells; Portland Meeting To Raise $8m; QRX Selects 12mg Morphine, 8mg Oxycodone Dose; Eastland Takes 78% Of Star Medical; ANZ Down To 18% Opes Prime's Bioprospect, 42% Solagran
May 21, 2008 Editorial: Taxation, Investment And Biotechnology; Starpharma Dendrimers 'Not Carbon Nanotubes'; Brazil Approves Cyclopharm's Technegas; 2nd US Patent For Advanced Surgical; Prana Places $7m; Genera IPO Oversubscribed	May 20, 2008 Evado's Safe, Cheap Clinical Trial Software; Study Backs Atcor Central BP Test; Victoria: 'Funding Attracts Researchers, Boosts Economy'; Euro-Patent For Viralytics Anti-Cancer Virus	May 19, 2008 FDA Clarifies Bone's Pivotal Osteoporosis Trial; Germany Approves Pharmaxis' Aridol Test; Progen Denies; EG Capital Silent On ASIC Raid; Novogen Triphendiol Tumor Trial; Ventracor CEO Peter Crosby Contract Extended
May 16, 2008 Pfizer's Doors Open To Australian Biotech; Heartware Moves Back To US; Benitec To Raise $5.1m; Healthlinx Raises $511k; Ritract Reinstated	May 15, 2008 Neuron Phase III Glypromate Trial 'On-Track'; Progen Tests Polyamine Analog For Cancer; Pandemic Stockpiles Need Relenza - Resarchers; Uscom Monitors For Birmingham ICU	May 14, 2008 Budget 2008: Little Joy For Biotech, For Now; Prima On Road To Recovery; Brazil's Circadian Route To 15% Of Metabolic Via Edward St; Stem Cell US Purity Patent; Halcygen Files Ant-Fungal IND
May 13, 2008	May 12, 2008	May 9, 2008
May 8, 2008	May 7, 2008	May 6, 2008
May 5, 2008	May 2, 2008	May 1, 2008

• Biotech Daily Home
• CEO Interviews
• Marc Sinatra's BioGuides
• Editorials
• Back copies
• Employment & Classifieds
• Contact Us

Copyright 2007. All Rights Reserved | Biotech Daily, PO Box 5000, Carlton, Victoria |
Design by Webdesign Specialist Australia